Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Predisposition to Disease | 299 | 2023 | 17446 | 6.060 |
Why?
|
Polymorphism, Single Nucleotide | 311 | 2023 | 15520 | 5.670 |
Why?
|
Polymorphism, Genetic | 107 | 2023 | 4328 | 5.580 |
Why?
|
Breast Neoplasms | 269 | 2023 | 20824 | 5.370 |
Why?
|
Genome-Wide Association Study | 194 | 2023 | 12262 | 4.180 |
Why?
|
Case-Control Studies | 293 | 2023 | 21748 | 2.910 |
Why?
|
Genotype | 195 | 2023 | 12952 | 2.490 |
Why?
|
Colorectal Neoplasms | 73 | 2022 | 6773 | 2.470 |
Why?
|
Genetic Loci | 48 | 2022 | 2575 | 2.370 |
Why?
|
State Medicine | 7 | 2023 | 217 | 2.360 |
Why?
|
Genetic Variation | 69 | 2022 | 6542 | 2.090 |
Why?
|
Prostatic Neoplasms | 85 | 2023 | 11126 | 2.080 |
Why?
|
Risk Factors | 389 | 2023 | 72296 | 2.010 |
Why?
|
Public Health | 11 | 2023 | 2602 | 1.820 |
Why?
|
Dietary Fats | 37 | 2022 | 2016 | 1.710 |
Why?
|
Vitamin A | 31 | 2013 | 615 | 1.690 |
Why?
|
Osteoarthritis, Knee | 18 | 2024 | 1222 | 1.670 |
Why?
|
Postmenopause | 42 | 2018 | 2460 | 1.600 |
Why?
|
Menarche | 16 | 2017 | 516 | 1.560 |
Why?
|
Humans | 920 | 2024 | 744366 | 1.530 |
Why?
|
Skin Neoplasms | 41 | 2020 | 5692 | 1.520 |
Why?
|
Adenoma | 23 | 2009 | 2174 | 1.520 |
Why?
|
Vitamins | 28 | 2010 | 1623 | 1.480 |
Why?
|
Female | 690 | 2024 | 380193 | 1.470 |
Why?
|
Genome, Human | 38 | 2019 | 4420 | 1.470 |
Why?
|
Smoking | 66 | 2019 | 8987 | 1.460 |
Why?
|
Alleles | 62 | 2021 | 6933 | 1.450 |
Why?
|
Alcohol Drinking | 45 | 2022 | 3966 | 1.430 |
Why?
|
Molecular Epidemiology | 7 | 2020 | 468 | 1.430 |
Why?
|
Nurses | 59 | 2019 | 2462 | 1.390 |
Why?
|
Arthralgia | 2 | 2024 | 456 | 1.380 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 16 | 2012 | 284 | 1.370 |
Why?
|
Folic Acid | 27 | 2015 | 1300 | 1.360 |
Why?
|
Premenopause | 34 | 2021 | 1033 | 1.360 |
Why?
|
Diet | 63 | 2021 | 7937 | 1.320 |
Why?
|
Knee Joint | 9 | 2024 | 1680 | 1.310 |
Why?
|
Carotenoids | 15 | 2013 | 624 | 1.270 |
Why?
|
Middle Aged | 441 | 2024 | 213390 | 1.260 |
Why?
|
Osteoarthritis | 7 | 2023 | 1036 | 1.250 |
Why?
|
Prospective Studies | 232 | 2023 | 53290 | 1.230 |
Why?
|
Arylamine N-Acetyltransferase | 9 | 2023 | 86 | 1.210 |
Why?
|
Adult | 424 | 2023 | 214052 | 1.200 |
Why?
|
Contraceptives, Oral | 19 | 2017 | 564 | 1.190 |
Why?
|
Risk | 90 | 2021 | 9688 | 1.190 |
Why?
|
Linkage Disequilibrium | 48 | 2021 | 1997 | 1.180 |
Why?
|
Pregnancy Complications, Infectious | 31 | 2010 | 2026 | 1.150 |
Why?
|
Education, Public Health Professional | 3 | 2015 | 24 | 1.130 |
Why?
|
Receptors, Progesterone | 17 | 2022 | 1098 | 1.110 |
Why?
|
Meat | 14 | 2013 | 592 | 1.110 |
Why?
|
Carcinoma, Basal Cell | 22 | 2015 | 545 | 1.110 |
Why?
|
Menopause | 26 | 2022 | 1626 | 1.100 |
Why?
|
Odds Ratio | 90 | 2021 | 9849 | 1.090 |
Why?
|
Body Mass Index | 84 | 2024 | 12721 | 1.040 |
Why?
|
Cohort Studies | 184 | 2019 | 40559 | 1.020 |
Why?
|
Gonadal Steroid Hormones | 13 | 2017 | 711 | 0.980 |
Why?
|
Synovitis | 4 | 2017 | 209 | 0.980 |
Why?
|
Quantitative Trait Loci | 24 | 2021 | 2019 | 0.950 |
Why?
|
Medicine | 2 | 2023 | 946 | 0.940 |
Why?
|
Polychlorinated Biphenyls | 8 | 2007 | 245 | 0.930 |
Why?
|
Tanzania | 45 | 2010 | 1346 | 0.930 |
Why?
|
Multifactorial Inheritance | 9 | 2023 | 1195 | 0.930 |
Why?
|
Haplotypes | 39 | 2016 | 2779 | 0.930 |
Why?
|
Receptors, Estrogen | 27 | 2022 | 2190 | 0.920 |
Why?
|
Endometrial Neoplasms | 20 | 2020 | 1351 | 0.910 |
Why?
|
Chromosomes, Human, Pair 8 | 11 | 2016 | 460 | 0.910 |
Why?
|
Body Height | 19 | 2016 | 1578 | 0.890 |
Why?
|
DNA Repair | 14 | 2015 | 2046 | 0.880 |
Why?
|
Aromatase | 7 | 2009 | 147 | 0.880 |
Why?
|
Genetic Markers | 15 | 2015 | 2634 | 0.860 |
Why?
|
Genetic Testing | 9 | 2023 | 3444 | 0.850 |
Why?
|
DNA-Binding Proteins | 24 | 2015 | 9647 | 0.850 |
Why?
|
Hypertension | 9 | 2022 | 8479 | 0.830 |
Why?
|
Health Policy | 9 | 2020 | 2661 | 0.820 |
Why?
|
Vitamin B 12 | 9 | 2021 | 527 | 0.820 |
Why?
|
Aged | 244 | 2024 | 163288 | 0.820 |
Why?
|
Hair Color | 9 | 2011 | 136 | 0.810 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 6 | 2001 | 88 | 0.810 |
Why?
|
HIV Infections | 48 | 2010 | 16715 | 0.810 |
Why?
|
Infectious Disease Transmission, Vertical | 17 | 2009 | 1320 | 0.800 |
Why?
|
Genomics | 10 | 2019 | 5717 | 0.800 |
Why?
|
Life Style | 22 | 2021 | 3835 | 0.800 |
Why?
|
Quarantine | 2 | 2020 | 170 | 0.800 |
Why?
|
Diabetes Mellitus, Type 2 | 40 | 2024 | 11726 | 0.780 |
Why?
|
Insulin-Like Growth Factor I | 17 | 2017 | 2016 | 0.780 |
Why?
|
Neoplasms | 40 | 2019 | 21696 | 0.780 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 6 | 2002 | 63 | 0.770 |
Why?
|
HIV-1 | 28 | 2009 | 6939 | 0.770 |
Why?
|
Chromosome Mapping | 27 | 2020 | 4740 | 0.770 |
Why?
|
Selenium | 13 | 2021 | 405 | 0.740 |
Why?
|
Germ-Line Mutation | 12 | 2021 | 1788 | 0.740 |
Why?
|
Telomere | 9 | 2016 | 910 | 0.740 |
Why?
|
Exercise | 18 | 2022 | 5615 | 0.730 |
Why?
|
Superoxide Dismutase | 4 | 2008 | 596 | 0.730 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2213 | 0.730 |
Why?
|
Homosexuality, Female | 3 | 2020 | 156 | 0.730 |
Why?
|
Male | 312 | 2023 | 350115 | 0.730 |
Why?
|
Sunburn | 7 | 2006 | 155 | 0.720 |
Why?
|
Reproductive History | 3 | 2016 | 209 | 0.710 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 12 | 2016 | 424 | 0.700 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 7 | 2009 | 257 | 0.700 |
Why?
|
Receptors, Calcitriol | 8 | 2009 | 348 | 0.700 |
Why?
|
Melanoma | 25 | 2020 | 5511 | 0.670 |
Why?
|
Interferon Regulatory Factors | 3 | 2018 | 270 | 0.660 |
Why?
|
Homocysteine | 7 | 2013 | 647 | 0.650 |
Why?
|
Schools, Public Health | 2 | 2015 | 22 | 0.650 |
Why?
|
Apolipoproteins E | 3 | 2022 | 1438 | 0.650 |
Why?
|
Epidemiologic Studies | 5 | 2017 | 676 | 0.640 |
Why?
|
Gene Frequency | 35 | 2018 | 3587 | 0.640 |
Why?
|
Apolipoprotein E4 | 2 | 2022 | 668 | 0.630 |
Why?
|
Skin Pigmentation | 6 | 2011 | 282 | 0.630 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 85 | 0.630 |
Why?
|
Mendelian Randomization Analysis | 13 | 2022 | 967 | 0.620 |
Why?
|
Incidence | 73 | 2022 | 20952 | 0.620 |
Why?
|
Cartilage, Articular | 7 | 2017 | 1095 | 0.620 |
Why?
|
Vitamin E | 16 | 2011 | 869 | 0.620 |
Why?
|
Vegetables | 13 | 2009 | 1182 | 0.620 |
Why?
|
Endometriosis | 5 | 2006 | 839 | 0.610 |
Why?
|
Low Back Pain | 4 | 2018 | 956 | 0.610 |
Why?
|
Multivariate Analysis | 61 | 2019 | 12244 | 0.590 |
Why?
|
Carcinoma, Squamous Cell | 20 | 2014 | 4034 | 0.590 |
Why?
|
United States | 137 | 2019 | 69872 | 0.590 |
Why?
|
Logistic Models | 57 | 2021 | 13409 | 0.580 |
Why?
|
Estrogens | 19 | 2010 | 1566 | 0.580 |
Why?
|
Obesity | 42 | 2024 | 12746 | 0.580 |
Why?
|
Europe | 29 | 2022 | 3338 | 0.570 |
Why?
|
Chromosomes, Human, Pair 5 | 8 | 2016 | 403 | 0.570 |
Why?
|
Dietary Supplements | 24 | 2021 | 3296 | 0.570 |
Why?
|
Ovarian Neoplasms | 24 | 2019 | 4839 | 0.560 |
Why?
|
Risk Assessment | 69 | 2019 | 23336 | 0.560 |
Why?
|
Fruit | 11 | 2009 | 1142 | 0.560 |
Why?
|
Micronutrients | 3 | 2021 | 375 | 0.560 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 7 | 2015 | 188 | 0.550 |
Why?
|
Vitamin D | 17 | 2019 | 3224 | 0.550 |
Why?
|
Alcohol Dehydrogenase | 4 | 2007 | 119 | 0.540 |
Why?
|
Blood Pressure | 3 | 2022 | 8551 | 0.540 |
Why?
|
Vaccines | 2 | 2022 | 823 | 0.540 |
Why?
|
Hypercholesterolemia | 2 | 2022 | 1151 | 0.540 |
Why?
|
Disease Transmission, Infectious | 2 | 2020 | 547 | 0.530 |
Why?
|
Health Personnel | 6 | 2020 | 3219 | 0.520 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2355 | 0.520 |
Why?
|
Histiocytosis | 1 | 2015 | 40 | 0.520 |
Why?
|
Anthropometry | 9 | 2016 | 1350 | 0.520 |
Why?
|
Estrogen Replacement Therapy | 16 | 2022 | 1203 | 0.510 |
Why?
|
Therapeutic Human Experimentation | 1 | 2015 | 43 | 0.510 |
Why?
|
Preventive Medicine | 1 | 2017 | 264 | 0.510 |
Why?
|
BRCA1 Protein | 8 | 2021 | 1149 | 0.510 |
Why?
|
ABO Blood-Group System | 7 | 2015 | 367 | 0.510 |
Why?
|
Nutritional Physiological Phenomena | 6 | 2006 | 370 | 0.510 |
Why?
|
Ascorbic Acid | 13 | 2010 | 651 | 0.500 |
Why?
|
Urinary Bladder Neoplasms | 11 | 2023 | 2249 | 0.500 |
Why?
|
Steroid 17-alpha-Hydroxylase | 5 | 2007 | 98 | 0.500 |
Why?
|
Colonic Neoplasms | 12 | 2010 | 2542 | 0.500 |
Why?
|
Nails | 8 | 2007 | 292 | 0.490 |
Why?
|
Follow-Up Studies | 73 | 2021 | 39052 | 0.490 |
Why?
|
Cost of Illness | 3 | 2017 | 1860 | 0.490 |
Why?
|
Glutathione Peroxidase | 2 | 2006 | 255 | 0.480 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2016 | 658 | 0.480 |
Why?
|
Receptor, Melanocortin, Type 1 | 4 | 2011 | 76 | 0.480 |
Why?
|
Confidence Intervals | 29 | 2012 | 2971 | 0.480 |
Why?
|
Pancreatic Neoplasms | 17 | 2016 | 5263 | 0.480 |
Why?
|
Chromosomes, Human, Pair 15 | 4 | 2011 | 373 | 0.480 |
Why?
|
Epoxide Hydrolases | 2 | 2005 | 122 | 0.470 |
Why?
|
Glutathione Transferase | 4 | 2004 | 595 | 0.470 |
Why?
|
DNA Repair Enzymes | 6 | 2012 | 349 | 0.470 |
Why?
|
Internationality | 2 | 2022 | 1002 | 0.470 |
Why?
|
Spirurida Infections | 1 | 2013 | 3 | 0.460 |
Why?
|
Waist-Hip Ratio | 11 | 2019 | 517 | 0.460 |
Why?
|
Age Factors | 52 | 2019 | 18373 | 0.460 |
Why?
|
Proportional Hazards Models | 42 | 2021 | 12356 | 0.460 |
Why?
|
Posture | 1 | 2018 | 958 | 0.460 |
Why?
|
Ethics Committees, Research | 1 | 2015 | 194 | 0.460 |
Why?
|
Trace Elements | 3 | 2005 | 198 | 0.460 |
Why?
|
Ethics, Research | 1 | 2015 | 191 | 0.450 |
Why?
|
Codon | 3 | 2006 | 611 | 0.450 |
Why?
|
DNA Methylation | 11 | 2019 | 4285 | 0.450 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2005 | 2232 | 0.440 |
Why?
|
Health Services | 2 | 2018 | 758 | 0.440 |
Why?
|
Parkinson Disease | 3 | 2024 | 2775 | 0.440 |
Why?
|
Chromosomes, Human, Pair 14 | 3 | 2011 | 299 | 0.440 |
Why?
|
Chronic Disease | 10 | 2017 | 9145 | 0.430 |
Why?
|
Health Surveys | 14 | 2018 | 4036 | 0.430 |
Why?
|
Knowledge | 1 | 2014 | 181 | 0.430 |
Why?
|
Glucuronosyltransferase | 5 | 2012 | 128 | 0.420 |
Why?
|
Cholesterol, HDL | 7 | 2020 | 1813 | 0.420 |
Why?
|
Lung Neoplasms | 18 | 2019 | 13104 | 0.420 |
Why?
|
Poliomyelitis | 1 | 2013 | 103 | 0.420 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 3 | 2001 | 30 | 0.410 |
Why?
|
Body Constitution | 7 | 2004 | 278 | 0.410 |
Why?
|
Dairy Products | 4 | 2006 | 498 | 0.410 |
Why?
|
Toll-Like Receptor 6 | 2 | 2010 | 28 | 0.410 |
Why?
|
Body Weight | 14 | 2013 | 4671 | 0.400 |
Why?
|
Sexually Transmitted Diseases | 7 | 2000 | 623 | 0.400 |
Why?
|
Joint Instability | 2 | 2009 | 792 | 0.400 |
Why?
|
Climate Change | 1 | 2017 | 418 | 0.400 |
Why?
|
Uncertainty | 1 | 2016 | 735 | 0.390 |
Why?
|
Aldehyde Oxidoreductases | 2 | 2001 | 88 | 0.390 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2047 | 0.390 |
Why?
|
Genetic Association Studies | 18 | 2016 | 2703 | 0.390 |
Why?
|
Germ Cells | 3 | 2021 | 631 | 0.380 |
Why?
|
TCF Transcription Factors | 2 | 2008 | 140 | 0.380 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2019 | 1344 | 0.370 |
Why?
|
Government Regulation | 1 | 2015 | 522 | 0.370 |
Why?
|
Dietary Fiber | 10 | 2013 | 760 | 0.370 |
Why?
|
Women | 3 | 2001 | 230 | 0.370 |
Why?
|
Estrone | 6 | 2021 | 240 | 0.370 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 4 | 2004 | 871 | 0.370 |
Why?
|
Sunlight | 4 | 2008 | 325 | 0.370 |
Why?
|
Models, Genetic | 16 | 2016 | 3493 | 0.370 |
Why?
|
Sequence Analysis, DNA | 16 | 2021 | 4805 | 0.370 |
Why?
|
Transcription Factors | 10 | 2017 | 12207 | 0.360 |
Why?
|
Health Services Research | 1 | 2018 | 1836 | 0.360 |
Why?
|
Breast | 8 | 2022 | 1970 | 0.360 |
Why?
|
Weight-Bearing | 2 | 2009 | 515 | 0.360 |
Why?
|
Alcoholic Beverages | 3 | 2014 | 265 | 0.360 |
Why?
|
CD4 Lymphocyte Count | 10 | 2009 | 2560 | 0.360 |
Why?
|
Estradiol | 10 | 2012 | 2020 | 0.360 |
Why?
|
Telomerase | 6 | 2018 | 730 | 0.360 |
Why?
|
Dimethylnitrosamine | 1 | 2009 | 16 | 0.350 |
Why?
|
Penetrance | 3 | 2015 | 381 | 0.350 |
Why?
|
Neoplasms, Hormone-Dependent | 4 | 2015 | 415 | 0.350 |
Why?
|
Dementia | 1 | 2024 | 2518 | 0.350 |
Why?
|
Epidemiologic Methods | 7 | 2007 | 1364 | 0.350 |
Why?
|
Nitrosamines | 1 | 2009 | 87 | 0.340 |
Why?
|
Congresses as Topic | 1 | 2014 | 764 | 0.340 |
Why?
|
Adiposity | 8 | 2017 | 1806 | 0.340 |
Why?
|
Feeding Behavior | 17 | 2014 | 3188 | 0.340 |
Why?
|
Meta-Analysis as Topic | 19 | 2017 | 1342 | 0.340 |
Why?
|
Insecticides | 3 | 2001 | 195 | 0.340 |
Why?
|
Magnetic Resonance Imaging | 13 | 2023 | 35425 | 0.340 |
Why?
|
Nitrites | 1 | 2009 | 160 | 0.340 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2010 | 188 | 0.340 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2018 | 2949 | 0.340 |
Why?
|
Birth Weight | 6 | 2009 | 2069 | 0.340 |
Why?
|
Lumbar Vertebrae | 3 | 2007 | 1848 | 0.340 |
Why?
|
Anemia | 7 | 2010 | 1503 | 0.330 |
Why?
|
Regression Analysis | 26 | 2016 | 6459 | 0.330 |
Why?
|
Pregnancy | 60 | 2010 | 29144 | 0.330 |
Why?
|
Statistics as Topic | 5 | 2010 | 2373 | 0.330 |
Why?
|
Diet Surveys | 10 | 2009 | 1173 | 0.320 |
Why?
|
Weight Gain | 13 | 2023 | 2293 | 0.320 |
Why?
|
Myocardial Infarction | 8 | 2022 | 11718 | 0.320 |
Why?
|
Kallikreins | 4 | 2011 | 258 | 0.320 |
Why?
|
Biostatistics | 1 | 2010 | 161 | 0.320 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 4 | 2013 | 94 | 0.320 |
Why?
|
BRCA2 Protein | 4 | 2021 | 794 | 0.320 |
Why?
|
Leiomyoma | 3 | 1998 | 730 | 0.320 |
Why?
|
Population Surveillance | 8 | 2016 | 2616 | 0.320 |
Why?
|
beta Carotene | 6 | 2007 | 527 | 0.320 |
Why?
|
Genes, Neoplasm | 2 | 2011 | 376 | 0.320 |
Why?
|
Cartilage Diseases | 2 | 2023 | 160 | 0.320 |
Why?
|
Coronary Disease | 12 | 2007 | 6077 | 0.320 |
Why?
|
Fucosyltransferases | 1 | 2008 | 119 | 0.320 |
Why?
|
Scavenger Receptors, Class A | 1 | 2008 | 54 | 0.320 |
Why?
|
Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.320 |
Why?
|
Models, Statistical | 10 | 2016 | 5101 | 0.320 |
Why?
|
Chromosomes, Human, Pair 2 | 4 | 2016 | 326 | 0.320 |
Why?
|
Prevalence | 26 | 2021 | 15221 | 0.310 |
Why?
|
HIV Seropositivity | 9 | 2006 | 971 | 0.310 |
Why?
|
Age of Onset | 6 | 2021 | 3270 | 0.310 |
Why?
|
Cyclooxygenase 2 | 2 | 2009 | 612 | 0.310 |
Why?
|
Polymerase Chain Reaction | 17 | 2016 | 6171 | 0.310 |
Why?
|
Sulfonamides | 2 | 2015 | 1940 | 0.310 |
Why?
|
Nitrates | 1 | 2009 | 265 | 0.310 |
Why?
|
Toll-Like Receptor 1 | 1 | 2007 | 48 | 0.310 |
Why?
|
Chromosomes, Human, Pair 12 | 3 | 2016 | 462 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3135 | 0.310 |
Why?
|
Biological Specimen Banks | 2 | 2024 | 711 | 0.310 |
Why?
|
Antiporters | 2 | 2009 | 277 | 0.310 |
Why?
|
Sexual Behavior | 10 | 2006 | 2055 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3242 | 0.310 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 4 | 2010 | 123 | 0.310 |
Why?
|
Family Planning Services | 5 | 2000 | 263 | 0.310 |
Why?
|
Macular Degeneration | 3 | 2015 | 980 | 0.300 |
Why?
|
Adipose Tissue | 9 | 2016 | 3280 | 0.300 |
Why?
|
One-Carbon Group Transferases | 1 | 2007 | 6 | 0.300 |
Why?
|
Genes | 3 | 2013 | 1893 | 0.300 |
Why?
|
Chromosomes, Human, Pair 19 | 4 | 2014 | 367 | 0.300 |
Why?
|
Mosaicism | 3 | 2016 | 441 | 0.300 |
Why?
|
Inheritance Patterns | 4 | 2019 | 340 | 0.300 |
Why?
|
Genes, BRCA2 | 3 | 2015 | 618 | 0.300 |
Why?
|
DNA, Neoplasm | 5 | 2009 | 1758 | 0.300 |
Why?
|
Gout | 4 | 2019 | 573 | 0.300 |
Why?
|
Ethanol | 5 | 2005 | 1342 | 0.300 |
Why?
|
Cyclin D1 | 2 | 2006 | 463 | 0.300 |
Why?
|
Mutation | 20 | 2021 | 29786 | 0.290 |
Why?
|
Breast Feeding | 6 | 2016 | 1338 | 0.290 |
Why?
|
Cardiovascular Diseases | 16 | 2022 | 15160 | 0.290 |
Why?
|
Phenotype | 27 | 2020 | 16367 | 0.290 |
Why?
|
Membrane Proteins | 11 | 2023 | 7882 | 0.290 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.290 |
Why?
|
Antioxidants | 8 | 2008 | 1659 | 0.290 |
Why?
|
Receptors, Androgen | 5 | 2010 | 1058 | 0.290 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2012 | 548 | 0.280 |
Why?
|
Gene Expression | 5 | 2018 | 7798 | 0.280 |
Why?
|
Dietary Proteins | 6 | 2014 | 963 | 0.280 |
Why?
|
Genes, BRCA1 | 3 | 2015 | 781 | 0.280 |
Why?
|
Calcium, Dietary | 3 | 2006 | 526 | 0.280 |
Why?
|
Toll-Like Receptor 4 | 2 | 2010 | 565 | 0.280 |
Why?
|
Reproducibility of Results | 37 | 2018 | 19905 | 0.280 |
Why?
|
Pandemics | 4 | 2020 | 8385 | 0.280 |
Why?
|
Promoter Regions, Genetic | 13 | 2016 | 5867 | 0.280 |
Why?
|
Prognosis | 32 | 2021 | 29060 | 0.280 |
Why?
|
Microsatellite Repeats | 4 | 2010 | 802 | 0.280 |
Why?
|
Chromosomes, Human, Pair 10 | 4 | 2011 | 287 | 0.280 |
Why?
|
Prostatic Secretory Proteins | 3 | 2010 | 25 | 0.270 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2007 | 314 | 0.270 |
Why?
|
Energy Intake | 15 | 2018 | 2148 | 0.270 |
Why?
|
Cytochrome P-450 CYP1A1 | 4 | 2003 | 91 | 0.270 |
Why?
|
Arginine | 2 | 2006 | 944 | 0.270 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2043 | 0.270 |
Why?
|
Biosynthetic Pathways | 1 | 2006 | 137 | 0.270 |
Why?
|
Spinal Stenosis | 1 | 2009 | 255 | 0.270 |
Why?
|
Spondylolisthesis | 1 | 2007 | 163 | 0.270 |
Why?
|
Tumor Suppressor Proteins | 6 | 2016 | 2850 | 0.270 |
Why?
|
Double-Blind Method | 19 | 2019 | 12025 | 0.270 |
Why?
|
Empirical Research | 1 | 2006 | 120 | 0.260 |
Why?
|
Adiponectin | 6 | 2014 | 1101 | 0.260 |
Why?
|
Environmental Exposure | 7 | 2014 | 4232 | 0.260 |
Why?
|
Body Size | 4 | 2016 | 461 | 0.260 |
Why?
|
Hormones | 4 | 2010 | 889 | 0.260 |
Why?
|
Anterior Cruciate Ligament | 1 | 2009 | 415 | 0.260 |
Why?
|
Tocopherols | 1 | 2005 | 43 | 0.260 |
Why?
|
Zygapophyseal Joint | 1 | 2007 | 129 | 0.250 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2007 | 303 | 0.250 |
Why?
|
Genes, ras | 2 | 2008 | 690 | 0.250 |
Why?
|
Aged, 80 and over | 48 | 2021 | 57776 | 0.250 |
Why?
|
Sample Size | 5 | 2022 | 845 | 0.250 |
Why?
|
Genes, erbB-2 | 1 | 2005 | 162 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 738 | 0.250 |
Why?
|
Environment | 4 | 2011 | 1123 | 0.250 |
Why?
|
Immunologic Factors | 2 | 2019 | 1580 | 0.250 |
Why?
|
Carcinoma | 7 | 2011 | 2375 | 0.250 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2004 | 54 | 0.250 |
Why?
|
Diethylstilbestrol | 1 | 2004 | 93 | 0.250 |
Why?
|
Cytochrome P-450 CYP1A2 | 3 | 2014 | 68 | 0.250 |
Why?
|
Chromosomes, Human, Pair 18 | 5 | 2011 | 245 | 0.250 |
Why?
|
Uterine Neoplasms | 3 | 1998 | 1513 | 0.250 |
Why?
|
Glycine Hydroxymethyltransferase | 3 | 2010 | 32 | 0.250 |
Why?
|
Malaria | 4 | 2013 | 1239 | 0.250 |
Why?
|
Evidence-Based Medicine | 5 | 2019 | 3611 | 0.250 |
Why?
|
Cognition | 2 | 2019 | 6770 | 0.240 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2004 | 2408 | 0.240 |
Why?
|
Australia | 6 | 2015 | 1167 | 0.240 |
Why?
|
Principal Component Analysis | 7 | 2016 | 940 | 0.240 |
Why?
|
Mammography | 7 | 2012 | 2475 | 0.240 |
Why?
|
Policy Making | 2 | 2018 | 554 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2017 | 8432 | 0.240 |
Why?
|
Patellofemoral Pain Syndrome | 1 | 2023 | 15 | 0.240 |
Why?
|
Genetics, Population | 3 | 2014 | 934 | 0.240 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2005 | 224 | 0.240 |
Why?
|
Osteoarthritis, Hip | 2 | 2023 | 412 | 0.230 |
Why?
|
Glioma | 4 | 2013 | 3401 | 0.230 |
Why?
|
Pregnancy, Multiple | 1 | 2004 | 217 | 0.230 |
Why?
|
Carcinogens | 4 | 2012 | 466 | 0.230 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2007 | 378 | 0.230 |
Why?
|
Estrogen Receptor alpha | 6 | 2017 | 577 | 0.230 |
Why?
|
Chromosomes, Human, Pair 9 | 4 | 2015 | 535 | 0.230 |
Why?
|
Bisexuality | 3 | 2020 | 269 | 0.230 |
Why?
|
Eating | 4 | 2013 | 1536 | 0.230 |
Why?
|
Minerals | 1 | 2005 | 275 | 0.230 |
Why?
|
Homozygote | 7 | 2008 | 1787 | 0.230 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 644 | 0.230 |
Why?
|
HIV Seroprevalence | 3 | 2006 | 86 | 0.230 |
Why?
|
Parity | 12 | 2010 | 929 | 0.230 |
Why?
|
Disease | 1 | 2009 | 680 | 0.230 |
Why?
|
Body Fat Distribution | 3 | 2017 | 244 | 0.220 |
Why?
|
Athletic Performance | 1 | 2024 | 95 | 0.220 |
Why?
|
Caffeine | 3 | 2015 | 699 | 0.220 |
Why?
|
Nevus, Pigmented | 2 | 2018 | 219 | 0.220 |
Why?
|
Tobacco Use Disorder | 3 | 2019 | 688 | 0.220 |
Why?
|
Dinucleotide Repeats | 1 | 2002 | 30 | 0.220 |
Why?
|
Minisatellite Repeats | 1 | 2003 | 165 | 0.220 |
Why?
|
Cross-Sectional Studies | 28 | 2024 | 25039 | 0.220 |
Why?
|
Depression | 6 | 2018 | 7759 | 0.220 |
Why?
|
Methionine | 7 | 2007 | 590 | 0.220 |
Why?
|
Aging | 8 | 2021 | 8664 | 0.220 |
Why?
|
Cooking | 6 | 2014 | 313 | 0.220 |
Why?
|
Zinc | 3 | 2005 | 684 | 0.220 |
Why?
|
Beauty Culture | 2 | 2013 | 41 | 0.220 |
Why?
|
Tandem Repeat Sequences | 1 | 2003 | 185 | 0.220 |
Why?
|
Chromosomes, Human, Pair 7 | 3 | 2019 | 322 | 0.220 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2016 | 197 | 0.220 |
Why?
|
Condoms | 4 | 2009 | 323 | 0.220 |
Why?
|
Aspirin | 9 | 2013 | 3283 | 0.220 |
Why?
|
Caspases | 1 | 2006 | 928 | 0.220 |
Why?
|
Research Design | 16 | 2019 | 5984 | 0.210 |
Why?
|
Genetics, Medical | 1 | 2005 | 338 | 0.210 |
Why?
|
Disease Progression | 16 | 2017 | 13286 | 0.210 |
Why?
|
Codon, Terminator | 1 | 2002 | 127 | 0.210 |
Why?
|
Calcaneus | 2 | 2001 | 138 | 0.210 |
Why?
|
Contraception | 3 | 1997 | 359 | 0.210 |
Why?
|
Genetic Research | 2 | 2006 | 174 | 0.210 |
Why?
|
Age Distribution | 11 | 2017 | 2902 | 0.210 |
Why?
|
Mammary Glands, Human | 2 | 2014 | 199 | 0.210 |
Why?
|
Pregnancy Outcome | 8 | 2009 | 2795 | 0.210 |
Why?
|
Nerve Tissue Proteins | 6 | 2018 | 4463 | 0.200 |
Why?
|
Medical History Taking | 6 | 2021 | 784 | 0.200 |
Why?
|
Triglycerides | 4 | 2022 | 2453 | 0.200 |
Why?
|
Proteins | 8 | 2015 | 6100 | 0.200 |
Why?
|
Interleukin-6 | 4 | 2019 | 3203 | 0.200 |
Why?
|
History, 20th Century | 4 | 2020 | 2740 | 0.200 |
Why?
|
Adolescent | 49 | 2017 | 85779 | 0.200 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1159 | 0.200 |
Why?
|
Review Literature as Topic | 1 | 2024 | 336 | 0.200 |
Why?
|
Women's Health | 11 | 2013 | 2034 | 0.200 |
Why?
|
Canada | 4 | 2018 | 2065 | 0.200 |
Why?
|
Pregnanediol | 1 | 2021 | 18 | 0.200 |
Why?
|
Residence Characteristics | 4 | 2017 | 2050 | 0.200 |
Why?
|
Epigenesis, Genetic | 6 | 2019 | 3646 | 0.200 |
Why?
|
Genetic Pleiotropy | 2 | 2021 | 182 | 0.190 |
Why?
|
Vitamin B Complex | 3 | 2015 | 288 | 0.190 |
Why?
|
DNA Helicases | 2 | 2012 | 861 | 0.190 |
Why?
|
Anemia, Iron-Deficiency | 4 | 2010 | 365 | 0.190 |
Why?
|
National Cancer Institute (U.S.) | 5 | 2013 | 288 | 0.190 |
Why?
|
Ultraviolet Rays | 4 | 2014 | 1060 | 0.190 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 115 | 0.190 |
Why?
|
Diabetic Angiopathies | 4 | 2006 | 818 | 0.190 |
Why?
|
Bedding and Linens | 1 | 2000 | 41 | 0.180 |
Why?
|
Neoplasm Proteins | 5 | 2019 | 3707 | 0.180 |
Why?
|
Range of Motion, Articular | 4 | 2022 | 1578 | 0.180 |
Why?
|
Adenocarcinoma | 6 | 2015 | 6364 | 0.180 |
Why?
|
Disease Susceptibility | 11 | 2018 | 1782 | 0.180 |
Why?
|
Receptor, erbB-2 | 4 | 2022 | 2417 | 0.180 |
Why?
|
Puberty | 2 | 2017 | 490 | 0.180 |
Why?
|
Iron | 4 | 2007 | 1774 | 0.180 |
Why?
|
Dietary Carbohydrates | 4 | 2014 | 905 | 0.180 |
Why?
|
North America | 8 | 2010 | 1249 | 0.180 |
Why?
|
Time Factors | 33 | 2020 | 40075 | 0.180 |
Why?
|
Oxidative Stress | 6 | 2009 | 3084 | 0.180 |
Why?
|
Obesity, Abdominal | 2 | 2022 | 361 | 0.180 |
Why?
|
Mental Health | 3 | 2017 | 3010 | 0.180 |
Why?
|
Membrane Glycoproteins | 3 | 2011 | 3771 | 0.180 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2017 | 1677 | 0.180 |
Why?
|
Cooperative Behavior | 6 | 2013 | 1504 | 0.180 |
Why?
|
Insulin | 4 | 2019 | 6582 | 0.180 |
Why?
|
Carcinoma in Situ | 3 | 2015 | 806 | 0.180 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2014 | 437 | 0.180 |
Why?
|
Transcription Factor 7-Like 2 Protein | 4 | 2023 | 154 | 0.180 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2002 | 419 | 0.180 |
Why?
|
Infant, Newborn | 23 | 2017 | 25628 | 0.180 |
Why?
|
Acne Vulgaris | 2 | 2015 | 302 | 0.180 |
Why?
|
Long Interspersed Nucleotide Elements | 3 | 2010 | 338 | 0.170 |
Why?
|
Epistasis, Genetic | 5 | 2017 | 365 | 0.170 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 216 | 0.170 |
Why?
|
Environmental Pollution | 2 | 2017 | 118 | 0.170 |
Why?
|
Antigens, Viral | 2 | 2020 | 1035 | 0.170 |
Why?
|
Electricity | 1 | 2000 | 182 | 0.170 |
Why?
|
Twins | 1 | 2001 | 339 | 0.170 |
Why?
|
Reproduction | 4 | 2015 | 668 | 0.170 |
Why?
|
False Positive Reactions | 3 | 2012 | 980 | 0.170 |
Why?
|
Coffee | 3 | 2015 | 578 | 0.170 |
Why?
|
Infertility, Female | 6 | 2006 | 788 | 0.170 |
Why?
|
Signal Transduction | 13 | 2020 | 23404 | 0.170 |
Why?
|
Sensitivity and Specificity | 17 | 2010 | 14723 | 0.170 |
Why?
|
Neoplasm Staging | 12 | 2021 | 11031 | 0.170 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 215 | 0.170 |
Why?
|
Medical Oncology | 3 | 2016 | 2267 | 0.170 |
Why?
|
T-Lymphocyte Subsets | 2 | 2005 | 1837 | 0.160 |
Why?
|
Ovary | 2 | 2021 | 981 | 0.160 |
Why?
|
Pain | 4 | 2024 | 4988 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2418 | 0.160 |
Why?
|
Hyperlipidemias | 2 | 2022 | 789 | 0.160 |
Why?
|
Fishes | 4 | 2003 | 569 | 0.160 |
Why?
|
Prostate-Specific Antigen | 5 | 2012 | 2494 | 0.160 |
Why?
|
Reference Values | 10 | 2009 | 4982 | 0.160 |
Why?
|
Primary Ovarian Insufficiency | 3 | 2021 | 115 | 0.160 |
Why?
|
DNA Modification Methylases | 3 | 2009 | 206 | 0.160 |
Why?
|
Laparoscopy | 4 | 2005 | 2150 | 0.160 |
Why?
|
DNA Damage | 3 | 2015 | 2432 | 0.160 |
Why?
|
Eggs | 3 | 2006 | 184 | 0.160 |
Why?
|
Chromosomes, Human | 2 | 2011 | 457 | 0.160 |
Why?
|
Football | 1 | 2024 | 460 | 0.160 |
Why?
|
Nutrition Therapy | 1 | 2019 | 96 | 0.160 |
Why?
|
Workload | 1 | 2004 | 849 | 0.160 |
Why?
|
Fatty Acids | 4 | 1999 | 1809 | 0.160 |
Why?
|
Estrogen Receptor beta | 3 | 2008 | 175 | 0.160 |
Why?
|
Membrane Transport Proteins | 4 | 2011 | 1031 | 0.160 |
Why?
|
Work Schedule Tolerance | 3 | 2012 | 563 | 0.160 |
Why?
|
ROC Curve | 8 | 2017 | 3528 | 0.160 |
Why?
|
Menisci, Tibial | 2 | 2017 | 269 | 0.160 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2000 | 431 | 0.160 |
Why?
|
Heterozygote | 9 | 2017 | 2804 | 0.160 |
Why?
|
Income | 2 | 2022 | 1913 | 0.160 |
Why?
|
Mental Recall | 5 | 2006 | 1206 | 0.160 |
Why?
|
Linear Models | 11 | 2013 | 5953 | 0.160 |
Why?
|
Diet Records | 4 | 1998 | 425 | 0.150 |
Why?
|
History, 21st Century | 3 | 2020 | 1534 | 0.150 |
Why?
|
Sex Characteristics | 7 | 2015 | 2585 | 0.150 |
Why?
|
Gene Expression Regulation | 6 | 2019 | 12073 | 0.150 |
Why?
|
Cytosine | 1 | 2019 | 216 | 0.150 |
Why?
|
Receptor, Melanocortin, Type 4 | 2 | 2008 | 129 | 0.150 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 2016 | 133 | 0.150 |
Why?
|
Vitamin D Deficiency | 5 | 2011 | 1343 | 0.150 |
Why?
|
Brain Neoplasms | 4 | 2013 | 8861 | 0.150 |
Why?
|
Amino Acid Substitution | 5 | 2007 | 1793 | 0.150 |
Why?
|
Catechol O-Methyltransferase | 3 | 2004 | 245 | 0.150 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 2 | 2007 | 13 | 0.150 |
Why?
|
Isoenzymes | 2 | 2001 | 1728 | 0.150 |
Why?
|
Human Genome Project | 3 | 2006 | 193 | 0.150 |
Why?
|
Exudates and Transudates | 1 | 2017 | 172 | 0.150 |
Why?
|
Retinoids | 1 | 1997 | 101 | 0.150 |
Why?
|
Hormone Replacement Therapy | 4 | 2022 | 745 | 0.150 |
Why?
|
Environmental Monitoring | 2 | 2009 | 1414 | 0.150 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 127 | 0.150 |
Why?
|
Ribonucleoproteins | 2 | 2017 | 381 | 0.150 |
Why?
|
Likelihood Functions | 7 | 2010 | 1005 | 0.140 |
Why?
|
Anticarcinogenic Agents | 2 | 2013 | 253 | 0.140 |
Why?
|
Menopause, Premature | 2 | 2021 | 132 | 0.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2001 | 3922 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 5 | 2015 | 1381 | 0.140 |
Why?
|
Internet | 5 | 2017 | 3056 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 2 | 2023 | 1085 | 0.140 |
Why?
|
Menstrual Cycle | 5 | 2024 | 551 | 0.140 |
Why?
|
Complement Factor H | 2 | 2007 | 110 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5223 | 0.140 |
Why?
|
Infant Mortality | 5 | 2009 | 754 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2013 | 2282 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2001 | 1041 | 0.140 |
Why?
|
Circumcision, Male | 2 | 1998 | 150 | 0.140 |
Why?
|
Genetic Linkage | 4 | 2013 | 2421 | 0.140 |
Why?
|
Progesterone | 1 | 2021 | 775 | 0.140 |
Why?
|
Data Collection | 4 | 2006 | 3339 | 0.140 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.140 |
Why?
|
Amines | 2 | 2013 | 276 | 0.140 |
Why?
|
Gonorrhea | 3 | 1998 | 335 | 0.140 |
Why?
|
Microfilament Proteins | 5 | 2018 | 1152 | 0.140 |
Why?
|
Lactation | 3 | 2004 | 412 | 0.140 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 2 | 2007 | 105 | 0.140 |
Why?
|
Mass Screening | 4 | 2020 | 5253 | 0.140 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 2 | 2006 | 55 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 604 | 0.140 |
Why?
|
Capacity Building | 1 | 2018 | 248 | 0.130 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 67 | 0.130 |
Why?
|
Uterine Cervical Dysplasia | 1 | 1999 | 387 | 0.130 |
Why?
|
Shoes | 1 | 2016 | 97 | 0.130 |
Why?
|
Stomatognathic Diseases | 1 | 2015 | 21 | 0.130 |
Why?
|
Blood Specimen Collection | 1 | 1997 | 246 | 0.130 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 3 | 2013 | 167 | 0.130 |
Why?
|
Peer Group | 1 | 2020 | 635 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2001 | 570 | 0.130 |
Why?
|
Androgens | 3 | 2005 | 1281 | 0.130 |
Why?
|
Toes | 5 | 1996 | 206 | 0.130 |
Why?
|
Therapy, Computer-Assisted | 1 | 2017 | 271 | 0.130 |
Why?
|
DNA | 7 | 2013 | 7294 | 0.130 |
Why?
|
Synovial Membrane | 2 | 2009 | 507 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.130 |
Why?
|
E-Selectin | 2 | 2010 | 579 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 381 | 0.130 |
Why?
|
Lactose | 2 | 2006 | 95 | 0.130 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2015 | 77 | 0.130 |
Why?
|
Environmental Health | 1 | 2017 | 278 | 0.130 |
Why?
|
Lymphedema | 1 | 2022 | 534 | 0.130 |
Why?
|
Quantitative Trait, Heritable | 2 | 2016 | 544 | 0.130 |
Why?
|
Molecular Sequence Annotation | 4 | 2021 | 528 | 0.130 |
Why?
|
Quality Control | 6 | 2013 | 841 | 0.130 |
Why?
|
Local Government | 1 | 2015 | 79 | 0.130 |
Why?
|
Health Education | 2 | 1993 | 1056 | 0.130 |
Why?
|
Informed Consent | 2 | 2001 | 995 | 0.130 |
Why?
|
CpG Islands | 2 | 2010 | 1170 | 0.130 |
Why?
|
Multiple Sclerosis | 3 | 2011 | 3079 | 0.130 |
Why?
|
Dyssomnias | 1 | 2014 | 29 | 0.130 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.130 |
Why?
|
Metabolic Networks and Pathways | 4 | 2013 | 783 | 0.130 |
Why?
|
Databases, Genetic | 7 | 2021 | 1783 | 0.130 |
Why?
|
Foundations | 1 | 2015 | 94 | 0.130 |
Why?
|
Proline | 3 | 2006 | 458 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2006 | 2943 | 0.120 |
Why?
|
Chlamydia Infections | 2 | 2003 | 365 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2014 | 3921 | 0.120 |
Why?
|
Beverages | 2 | 2012 | 821 | 0.120 |
Why?
|
Foreign Professional Personnel | 1 | 2014 | 9 | 0.120 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 296 | 0.120 |
Why?
|
Syphilis | 2 | 1994 | 227 | 0.120 |
Why?
|
Phosphofructokinase-1, Muscle Type | 1 | 2014 | 3 | 0.120 |
Why?
|
Epidemiologic Research Design | 2 | 2003 | 367 | 0.120 |
Why?
|
Introns | 5 | 2017 | 992 | 0.120 |
Why?
|
Probability | 5 | 2009 | 2506 | 0.120 |
Why?
|
Financial Support | 1 | 2015 | 115 | 0.120 |
Why?
|
Trichomonas Vaginitis | 1 | 1994 | 35 | 0.120 |
Why?
|
Inflammation | 4 | 2015 | 10637 | 0.120 |
Why?
|
Developed Countries | 2 | 2013 | 437 | 0.120 |
Why?
|
Sexual Partners | 6 | 2009 | 729 | 0.120 |
Why?
|
Dissent and Disputes | 1 | 2015 | 141 | 0.120 |
Why?
|
Education, Graduate | 1 | 2015 | 81 | 0.120 |
Why?
|
Radiation, Ionizing | 2 | 2010 | 258 | 0.120 |
Why?
|
Cholesterol | 5 | 2016 | 2919 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 224 | 0.120 |
Why?
|
Caspase 8 | 1 | 2014 | 195 | 0.120 |
Why?
|
Receptors, Nicotinic | 2 | 2015 | 497 | 0.120 |
Why?
|
DNA Ligases | 2 | 2004 | 80 | 0.120 |
Why?
|
Prenatal Care | 5 | 2009 | 1092 | 0.120 |
Why?
|
Cyclin E | 1 | 2014 | 172 | 0.120 |
Why?
|
Longitudinal Studies | 12 | 2022 | 13991 | 0.120 |
Why?
|
Somatotypes | 1 | 1994 | 42 | 0.120 |
Why?
|
DNA Primers | 4 | 2007 | 2891 | 0.120 |
Why?
|
Mental Disorders | 2 | 2019 | 6598 | 0.120 |
Why?
|
PPAR gamma | 3 | 2007 | 493 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 501 | 0.120 |
Why?
|
HIV Wasting Syndrome | 2 | 2005 | 97 | 0.120 |
Why?
|
Athletic Injuries | 1 | 2024 | 1154 | 0.120 |
Why?
|
Casein Kinase II | 1 | 2014 | 128 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2017 | 847 | 0.120 |
Why?
|
Urbanization | 1 | 2014 | 104 | 0.110 |
Why?
|
Arsenic | 3 | 2007 | 328 | 0.110 |
Why?
|
Lipase | 2 | 2006 | 314 | 0.110 |
Why?
|
Xenobiotics | 1 | 2013 | 73 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 286 | 0.110 |
Why?
|
Glycine | 2 | 2014 | 671 | 0.110 |
Why?
|
Humidity | 1 | 2014 | 197 | 0.110 |
Why?
|
Nutritional Status | 5 | 2010 | 1609 | 0.110 |
Why?
|
Alcoholism | 1 | 2004 | 1906 | 0.110 |
Why?
|
Sequence Deletion | 1 | 2018 | 1525 | 0.110 |
Why?
|
Economics | 1 | 2014 | 146 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 2 | 2002 | 582 | 0.110 |
Why?
|
Bayes Theorem | 5 | 2023 | 2307 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2005 | 2020 | 0.110 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2013 | 547 | 0.110 |
Why?
|
Social Behavior | 1 | 2020 | 1127 | 0.110 |
Why?
|
Hypersensitivity | 2 | 2013 | 1102 | 0.110 |
Why?
|
Proteomics | 1 | 2006 | 3638 | 0.110 |
Why?
|
Carcinoma, Lobular | 2 | 2013 | 484 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.110 |
Why?
|
Leucine | 2 | 2004 | 560 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 4 | 2009 | 3143 | 0.110 |
Why?
|
Cyclin D2 | 1 | 2012 | 101 | 0.110 |
Why?
|
Repetitive Sequences, Nucleic Acid | 3 | 2010 | 798 | 0.110 |
Why?
|
Gene Expression Profiling | 7 | 2018 | 9445 | 0.110 |
Why?
|
Kenya | 6 | 1995 | 685 | 0.110 |
Why?
|
Sunbathing | 2 | 2013 | 60 | 0.110 |
Why?
|
Ethics, Medical | 4 | 1999 | 792 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2013 | 211 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 484 | 0.110 |
Why?
|
Sex Factors | 12 | 2012 | 10400 | 0.110 |
Why?
|
Cross-Over Studies | 5 | 2022 | 2029 | 0.110 |
Why?
|
Demography | 3 | 2009 | 1655 | 0.110 |
Why?
|
Valine | 2 | 2004 | 413 | 0.110 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 66 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 1997 | 1401 | 0.110 |
Why?
|
Puberty, Delayed | 2 | 2010 | 115 | 0.110 |
Why?
|
Attitude to Health | 1 | 2001 | 2052 | 0.110 |
Why?
|
Milk | 3 | 2007 | 450 | 0.110 |
Why?
|
Suntan | 1 | 2012 | 17 | 0.110 |
Why?
|
Nutrition Surveys | 6 | 2010 | 1660 | 0.110 |
Why?
|
Health Care Reform | 2 | 2009 | 1261 | 0.110 |
Why?
|
Dystocia | 1 | 1992 | 34 | 0.110 |
Why?
|
Professional Practice | 1 | 2014 | 326 | 0.110 |
Why?
|
Hysterectomy | 5 | 1998 | 927 | 0.100 |
Why?
|
Health Priorities | 1 | 2015 | 380 | 0.100 |
Why?
|
Viral Load | 5 | 2007 | 3300 | 0.100 |
Why?
|
Pregnancy in Diabetics | 2 | 1993 | 179 | 0.100 |
Why?
|
Pesticide Residues | 1 | 1993 | 95 | 0.100 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13693 | 0.100 |
Why?
|
Neoplasm Invasiveness | 6 | 2021 | 3616 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 3 | 2010 | 20130 | 0.100 |
Why?
|
Waist Circumference | 5 | 2017 | 917 | 0.100 |
Why?
|
Receptors, LHRH | 2 | 2009 | 160 | 0.100 |
Why?
|
Mannose-Binding Lectin | 1 | 2013 | 150 | 0.100 |
Why?
|
Protein Isoforms | 3 | 2012 | 1730 | 0.100 |
Why?
|
Medical Records | 2 | 1997 | 1413 | 0.100 |
Why?
|
Chromosomes, Human, Pair 22 | 2 | 2010 | 351 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2015 | 1115 | 0.100 |
Why?
|
Area Under Curve | 3 | 2011 | 1655 | 0.100 |
Why?
|
Fetal Diseases | 3 | 2002 | 903 | 0.100 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2010 | 323 | 0.100 |
Why?
|
Antibodies, Viral | 2 | 2001 | 3177 | 0.100 |
Why?
|
Cervix Uteri | 2 | 1992 | 590 | 0.100 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2012 | 230 | 0.100 |
Why?
|
Fats, Unsaturated | 2 | 2003 | 21 | 0.100 |
Why?
|
Mortality | 6 | 2004 | 2864 | 0.100 |
Why?
|
Transcobalamins | 2 | 2010 | 18 | 0.100 |
Why?
|
Hot Temperature | 2 | 2014 | 1356 | 0.100 |
Why?
|
Marital Status | 3 | 2000 | 437 | 0.100 |
Why?
|
Mouth Mucosa | 3 | 2015 | 434 | 0.100 |
Why?
|
Exercise Therapy | 2 | 2009 | 904 | 0.100 |
Why?
|
Osteosarcoma | 2 | 2015 | 881 | 0.100 |
Why?
|
Analgesics | 2 | 2009 | 1040 | 0.100 |
Why?
|
Incidental Findings | 1 | 2016 | 689 | 0.100 |
Why?
|
Physical Chromosome Mapping | 1 | 2011 | 183 | 0.100 |
Why?
|
Chromosomes, Human, Y | 1 | 2012 | 148 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2011 | 2938 | 0.100 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1813 | 0.100 |
Why?
|
Lymphocyte Count | 4 | 2005 | 793 | 0.100 |
Why?
|
Self Care | 1 | 2016 | 786 | 0.100 |
Why?
|
Survival Analysis | 8 | 2021 | 10252 | 0.100 |
Why?
|
Alanine | 4 | 2009 | 572 | 0.100 |
Why?
|
Bone Density | 4 | 2010 | 3468 | 0.090 |
Why?
|
Developing Countries | 7 | 2017 | 2815 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 45 | 0.090 |
Why?
|
Leukocytes | 3 | 2014 | 2045 | 0.090 |
Why?
|
Amide Synthases | 1 | 2010 | 12 | 0.090 |
Why?
|
Population Groups | 2 | 2009 | 209 | 0.090 |
Why?
|
Drinking Behavior | 1 | 2011 | 103 | 0.090 |
Why?
|
Chlamydia trachomatis | 1 | 1992 | 246 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 4424 | 0.090 |
Why?
|
Acyl-CoA Dehydrogenase | 1 | 2010 | 58 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4042 | 0.090 |
Why?
|
Avitaminosis | 1 | 2010 | 34 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 59 | 0.090 |
Why?
|
Animals | 24 | 2021 | 168768 | 0.090 |
Why?
|
Selection Bias | 1 | 2012 | 371 | 0.090 |
Why?
|
Dietary Sucrose | 1 | 2012 | 246 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1403 | 0.090 |
Why?
|
Observation | 1 | 2012 | 312 | 0.090 |
Why?
|
Labor, Obstetric | 2 | 1999 | 333 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
Oxidoreductases | 2 | 2009 | 424 | 0.090 |
Why?
|
Tissue Kallikreins | 1 | 2009 | 15 | 0.090 |
Why?
|
Somatomedins | 1 | 2010 | 192 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2020 | 794 | 0.090 |
Why?
|
Jews | 1 | 2012 | 385 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6486 | 0.090 |
Why?
|
Folic Acid Deficiency | 2 | 2003 | 115 | 0.090 |
Why?
|
Statistics, Nonparametric | 4 | 2007 | 2887 | 0.090 |
Why?
|
3' Untranslated Regions | 2 | 2014 | 513 | 0.090 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.090 |
Why?
|
Mutation, Missense | 5 | 2008 | 2566 | 0.090 |
Why?
|
Receptors, Somatostatin | 1 | 2010 | 129 | 0.090 |
Why?
|
Affect | 1 | 2017 | 1475 | 0.090 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2009 | 17 | 0.090 |
Why?
|
Hypothalamus | 1 | 2015 | 1063 | 0.090 |
Why?
|
Educational Status | 6 | 2005 | 2540 | 0.090 |
Why?
|
Young Adult | 16 | 2021 | 56429 | 0.090 |
Why?
|
Lysophospholipase | 1 | 2009 | 63 | 0.090 |
Why?
|
Tea | 2 | 2008 | 275 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2018 | 5077 | 0.090 |
Why?
|
Calcifediol | 2 | 2007 | 166 | 0.090 |
Why?
|
Technology, Radiologic | 1 | 2010 | 163 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2010 | 1888 | 0.090 |
Why?
|
Patella | 2 | 2009 | 320 | 0.090 |
Why?
|
Hemoglobins | 4 | 2010 | 1532 | 0.090 |
Why?
|
Overweight | 5 | 2024 | 2371 | 0.090 |
Why?
|
Kidney Neoplasms | 4 | 2015 | 4262 | 0.090 |
Why?
|
Transcription Factor AP-2 | 1 | 2009 | 82 | 0.090 |
Why?
|
Glaucoma, Open-Angle | 1 | 2016 | 706 | 0.080 |
Why?
|
Diabetes Complications | 2 | 2013 | 1359 | 0.080 |
Why?
|
Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
Health Promotion | 3 | 2005 | 2205 | 0.080 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2005 | 1366 | 0.080 |
Why?
|
Carbon | 1 | 2013 | 687 | 0.080 |
Why?
|
Diffusion of Innovation | 1 | 2014 | 725 | 0.080 |
Why?
|
Puberty, Precocious | 1 | 2010 | 156 | 0.080 |
Why?
|
Blood Glucose | 4 | 2019 | 6254 | 0.080 |
Why?
|
Meat Products | 1 | 2009 | 99 | 0.080 |
Why?
|
Calcitriol | 2 | 2007 | 297 | 0.080 |
Why?
|
Forecasting | 4 | 2009 | 2951 | 0.080 |
Why?
|
Acrylamide | 1 | 2009 | 60 | 0.080 |
Why?
|
Biomedical Research | 2 | 2016 | 3309 | 0.080 |
Why?
|
Oxo-Acid-Lyases | 1 | 2008 | 22 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2017 | 13035 | 0.080 |
Why?
|
Genome, Mitochondrial | 1 | 2009 | 71 | 0.080 |
Why?
|
Safe Sex | 1 | 2009 | 141 | 0.080 |
Why?
|
Acetylation | 3 | 2016 | 1084 | 0.080 |
Why?
|
Hip Joint | 2 | 2009 | 1002 | 0.080 |
Why?
|
Morbidity | 4 | 2009 | 1768 | 0.080 |
Why?
|
Receptors, CXCR4 | 1 | 2013 | 727 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2011 | 9955 | 0.080 |
Why?
|
Uracil | 1 | 2009 | 165 | 0.080 |
Why?
|
Epidemiology | 2 | 2008 | 287 | 0.080 |
Why?
|
Air Pollution | 1 | 2022 | 2286 | 0.080 |
Why?
|
Allied Health Personnel | 1 | 2010 | 162 | 0.080 |
Why?
|
Interleukin-18 | 1 | 2010 | 249 | 0.080 |
Why?
|
beta Catenin | 1 | 2013 | 1059 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.080 |
Why?
|
Selenoproteins | 1 | 2010 | 216 | 0.080 |
Why?
|
Receptors, Leptin | 1 | 2010 | 361 | 0.080 |
Why?
|
Precancerous Conditions | 2 | 2010 | 975 | 0.080 |
Why?
|
Vitamin B 6 | 2 | 2015 | 237 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2009 | 163 | 0.080 |
Why?
|
Interviews as Topic | 2 | 2006 | 2539 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2011 | 1100 | 0.080 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2005 | 500 | 0.080 |
Why?
|
Comorbidity | 6 | 2017 | 10388 | 0.080 |
Why?
|
Menstruation | 3 | 2005 | 302 | 0.080 |
Why?
|
Recombination, Genetic | 4 | 2001 | 1586 | 0.080 |
Why?
|
Fats | 1 | 2008 | 102 | 0.080 |
Why?
|
Orthotic Devices | 1 | 2009 | 128 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 2 | 2008 | 1790 | 0.080 |
Why?
|
Multigene Family | 2 | 2010 | 1102 | 0.080 |
Why?
|
Pregnancy Complications, Parasitic | 2 | 2005 | 54 | 0.080 |
Why?
|
Blood Cells | 1 | 2010 | 309 | 0.080 |
Why?
|
Computational Biology | 5 | 2020 | 3519 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 281 | 0.080 |
Why?
|
Thrombophilia | 1 | 2010 | 305 | 0.080 |
Why?
|
Leptin | 1 | 2016 | 1600 | 0.080 |
Why?
|
Contraception Behavior | 3 | 1995 | 185 | 0.080 |
Why?
|
Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2017 | 15535 | 0.080 |
Why?
|
Base Sequence | 8 | 2012 | 12797 | 0.080 |
Why?
|
Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.080 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2001 | 386 | 0.080 |
Why?
|
Galectin 2 | 1 | 2007 | 13 | 0.070 |
Why?
|
Life Expectancy | 1 | 2014 | 1184 | 0.070 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5749 | 0.070 |
Why?
|
Receptors, Interleukin | 1 | 2008 | 245 | 0.070 |
Why?
|
Primary Health Care | 1 | 2024 | 4557 | 0.070 |
Why?
|
Choroidal Neovascularization | 1 | 2010 | 343 | 0.070 |
Why?
|
Infant | 14 | 2017 | 35134 | 0.070 |
Why?
|
Telomere-Binding Proteins | 2 | 2018 | 116 | 0.070 |
Why?
|
Predictive Value of Tests | 10 | 2015 | 15078 | 0.070 |
Why?
|
Receptors, Interleukin-6 | 1 | 2008 | 225 | 0.070 |
Why?
|
Steroids | 2 | 2010 | 930 | 0.070 |
Why?
|
Gene Regulatory Networks | 4 | 2020 | 1707 | 0.070 |
Why?
|
Chi-Square Distribution | 3 | 2008 | 3508 | 0.070 |
Why?
|
Cocarcinogenesis | 2 | 2004 | 54 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2017 | 5321 | 0.070 |
Why?
|
Vaccination | 1 | 2019 | 3279 | 0.070 |
Why?
|
Lymphotoxin-alpha | 1 | 2007 | 98 | 0.070 |
Why?
|
Joints | 1 | 2009 | 327 | 0.070 |
Why?
|
Uterus | 2 | 2021 | 711 | 0.070 |
Why?
|
Antigens, CD | 1 | 2017 | 4026 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 3 | 2016 | 380 | 0.070 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2007 | 110 | 0.070 |
Why?
|
Parturition | 1 | 2010 | 441 | 0.070 |
Why?
|
Smoking Cessation | 3 | 2015 | 2071 | 0.070 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 878 | 0.070 |
Why?
|
Testosterone | 3 | 2015 | 2419 | 0.070 |
Why?
|
Cerebrovascular Disorders | 3 | 1997 | 1504 | 0.070 |
Why?
|
Nuclear Proteins | 3 | 2018 | 5856 | 0.070 |
Why?
|
Health Occupations | 1 | 2008 | 224 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2004 | 769 | 0.070 |
Why?
|
Mothers | 3 | 2007 | 2165 | 0.070 |
Why?
|
Tibia | 2 | 2010 | 1077 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2015 | 1157 | 0.070 |
Why?
|
Models, Biological | 3 | 2015 | 9584 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2916 | 0.070 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 370 | 0.070 |
Why?
|
Exons | 4 | 2009 | 2439 | 0.070 |
Why?
|
Genomic Imprinting | 3 | 2017 | 328 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2012 | 2624 | 0.070 |
Why?
|
Child | 14 | 2017 | 77709 | 0.070 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1985 | 80 | 0.070 |
Why?
|
Matrix Metalloproteinases | 1 | 2008 | 391 | 0.070 |
Why?
|
Analysis of Variance | 5 | 2014 | 6366 | 0.070 |
Why?
|
Cell Adhesion Molecules | 3 | 2009 | 1602 | 0.070 |
Why?
|
Apolipoproteins A | 1 | 2006 | 94 | 0.070 |
Why?
|
DNA Mutational Analysis | 3 | 2019 | 4185 | 0.070 |
Why?
|
Contrast Media | 2 | 2017 | 5300 | 0.070 |
Why?
|
Multicenter Studies as Topic | 4 | 2008 | 1677 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 1994 | 520 | 0.070 |
Why?
|
Sterilization, Reproductive | 1 | 2005 | 21 | 0.070 |
Why?
|
Rad51 Recombinase | 2 | 2018 | 189 | 0.070 |
Why?
|
Intrauterine Devices | 3 | 1998 | 122 | 0.070 |
Why?
|
High Mobility Group Proteins | 3 | 2015 | 187 | 0.070 |
Why?
|
Infant, Low Birth Weight | 4 | 2005 | 850 | 0.070 |
Why?
|
Sodium Channels | 1 | 2007 | 349 | 0.070 |
Why?
|
Hair Dyes | 2 | 1996 | 30 | 0.070 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 836 | 0.070 |
Why?
|
Rural Population | 2 | 1993 | 2207 | 0.070 |
Why?
|
Immunity | 1 | 2012 | 1014 | 0.070 |
Why?
|
Immunoglobulin E | 1 | 2011 | 1463 | 0.070 |
Why?
|
Socioeconomic Factors | 5 | 2014 | 7785 | 0.070 |
Why?
|
Wasting Syndrome | 1 | 2006 | 101 | 0.070 |
Why?
|
RNA, Viral | 3 | 2006 | 2901 | 0.070 |
Why?
|
Information Services | 1 | 2007 | 244 | 0.070 |
Why?
|
Abortion, Habitual | 1 | 1985 | 70 | 0.070 |
Why?
|
National Health Programs | 1 | 2009 | 445 | 0.070 |
Why?
|
Color | 1 | 2006 | 307 | 0.070 |
Why?
|
Vesicular Transport Proteins | 1 | 2008 | 377 | 0.060 |
Why?
|
Sex Distribution | 5 | 2012 | 2297 | 0.060 |
Why?
|
Nociceptors | 1 | 2009 | 432 | 0.060 |
Why?
|
CD4-CD8 Ratio | 1 | 2005 | 112 | 0.060 |
Why?
|
Health Behavior | 4 | 2013 | 2635 | 0.060 |
Why?
|
Environmental Pollutants | 3 | 2007 | 1179 | 0.060 |
Why?
|
Brassica | 1 | 2004 | 38 | 0.060 |
Why?
|
Radiography | 3 | 2014 | 7023 | 0.060 |
Why?
|
Menorrhagia | 2 | 2003 | 63 | 0.060 |
Why?
|
Apolipoprotein A-I | 1 | 2006 | 281 | 0.060 |
Why?
|
Protein Precursors | 1 | 2009 | 1154 | 0.060 |
Why?
|
Enhancer Elements, Genetic | 3 | 2016 | 1340 | 0.060 |
Why?
|
Bone Remodeling | 1 | 2009 | 575 | 0.060 |
Why?
|
Parasitemia | 1 | 2005 | 173 | 0.060 |
Why?
|
Occupations | 2 | 2000 | 517 | 0.060 |
Why?
|
Apolipoprotein C-III | 1 | 2006 | 202 | 0.060 |
Why?
|
Nurse Clinicians | 1 | 2004 | 31 | 0.060 |
Why?
|
Carcinogens, Environmental | 1 | 2005 | 67 | 0.060 |
Why?
|
RNA-Binding Proteins | 3 | 2023 | 1903 | 0.060 |
Why?
|
Mountaineering | 1 | 1984 | 45 | 0.060 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2004 | 17 | 0.060 |
Why?
|
Physicians | 2 | 2005 | 4567 | 0.060 |
Why?
|
Acetaminophen | 1 | 2009 | 545 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2736 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 1988 | 570 | 0.060 |
Why?
|
Peroxidase | 1 | 2008 | 611 | 0.060 |
Why?
|
Students | 2 | 1992 | 1647 | 0.060 |
Why?
|
Genes, APC | 1 | 2005 | 159 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2010 | 10943 | 0.060 |
Why?
|
Genes, p53 | 1 | 2007 | 755 | 0.060 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2530 | 0.060 |
Why?
|
Nuclear Receptor Coactivator 3 | 2 | 2003 | 53 | 0.060 |
Why?
|
Fertility | 2 | 2021 | 781 | 0.060 |
Why?
|
Iron, Dietary | 1 | 2005 | 141 | 0.060 |
Why?
|
Glycemic Index | 2 | 2004 | 394 | 0.060 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2004 | 29 | 0.060 |
Why?
|
Homeostasis | 1 | 2015 | 3339 | 0.060 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2007 | 347 | 0.060 |
Why?
|
Allergens | 1 | 2011 | 1320 | 0.060 |
Why?
|
Registries | 6 | 2014 | 8091 | 0.060 |
Why?
|
MAP Kinase Kinase Kinase 1 | 3 | 2009 | 58 | 0.060 |
Why?
|
Menstruation Disturbances | 1 | 2005 | 148 | 0.060 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2004 | 77 | 0.060 |
Why?
|
Gout Suppressants | 1 | 2005 | 166 | 0.060 |
Why?
|
Progestins | 3 | 1997 | 306 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4554 | 0.060 |
Why?
|
Altitude Sickness | 1 | 1984 | 92 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 2 | 2002 | 816 | 0.060 |
Why?
|
Interleukins | 1 | 2008 | 791 | 0.060 |
Why?
|
Viral Proteins | 2 | 2001 | 1900 | 0.060 |
Why?
|
Endometrium | 2 | 2004 | 424 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2015 | 1431 | 0.060 |
Why?
|
Thymidylate Synthase | 1 | 2003 | 75 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2011 | 948 | 0.060 |
Why?
|
Child, Preschool | 9 | 2017 | 41005 | 0.060 |
Why?
|
Ovulation | 2 | 2002 | 189 | 0.060 |
Why?
|
Growth Hormone | 1 | 2006 | 705 | 0.060 |
Why?
|
Ataxia Telangiectasia | 1 | 2004 | 112 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1184 | 0.060 |
Why?
|
Mitomycin | 1 | 2004 | 259 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2023 | 2917 | 0.060 |
Why?
|
Child Mortality | 1 | 2005 | 198 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2006 | 689 | 0.060 |
Why?
|
Antifibrinolytic Agents | 1 | 2006 | 254 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.060 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6313 | 0.060 |
Why?
|
Hair | 1 | 2006 | 481 | 0.060 |
Why?
|
Prolactin | 2 | 1995 | 669 | 0.060 |
Why?
|
Microarray Analysis | 2 | 2017 | 767 | 0.060 |
Why?
|
DNA, Viral | 3 | 2006 | 2227 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 2 | 2018 | 1142 | 0.060 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 498 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2269 | 0.060 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2009 | 1206 | 0.060 |
Why?
|
Binding Sites | 3 | 2017 | 6111 | 0.050 |
Why?
|
Parvoviridae Infections | 1 | 2002 | 35 | 0.050 |
Why?
|
Steroid Hydroxylases | 2 | 2013 | 96 | 0.050 |
Why?
|
Parvovirus B19, Human | 1 | 2002 | 38 | 0.050 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 32 | 0.050 |
Why?
|
India | 2 | 2023 | 2197 | 0.050 |
Why?
|
Needs Assessment | 1 | 2009 | 1147 | 0.050 |
Why?
|
Social Class | 4 | 2006 | 1997 | 0.050 |
Why?
|
Heart Diseases | 1 | 2016 | 2789 | 0.050 |
Why?
|
Cause of Death | 7 | 2021 | 3582 | 0.050 |
Why?
|
Pharmacoepidemiology | 1 | 2006 | 323 | 0.050 |
Why?
|
Diarrhea | 3 | 2005 | 1348 | 0.050 |
Why?
|
Cattle | 2 | 1999 | 3922 | 0.050 |
Why?
|
MicroRNAs | 2 | 2018 | 3751 | 0.050 |
Why?
|
Hysteroscopy | 1 | 2003 | 102 | 0.050 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3086 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 2007 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3493 | 0.050 |
Why?
|
Molecular Sequence Data | 6 | 2007 | 18111 | 0.050 |
Why?
|
Private Practice | 1 | 1983 | 154 | 0.050 |
Why?
|
Fossil Fuels | 1 | 2022 | 44 | 0.050 |
Why?
|
Glycoproteins | 1 | 2010 | 2266 | 0.050 |
Why?
|
Biological Evolution | 1 | 2008 | 1077 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2018 | 5023 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2007 | 1158 | 0.050 |
Why?
|
Adipogenesis | 2 | 2015 | 359 | 0.050 |
Why?
|
Fibrocystic Breast Disease | 2 | 1999 | 102 | 0.050 |
Why?
|
Hypogonadism | 1 | 2008 | 799 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2017 | 5135 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 670 | 0.050 |
Why?
|
World Health Organization | 2 | 2018 | 1318 | 0.050 |
Why?
|
Phobic Disorders | 1 | 2004 | 439 | 0.050 |
Why?
|
Monoamine Oxidase | 1 | 2002 | 178 | 0.050 |
Why?
|
Intestinal Mucosa | 2 | 2010 | 3037 | 0.050 |
Why?
|
Oligomenorrhea | 1 | 2001 | 45 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2015 | 894 | 0.050 |
Why?
|
Heart Rate | 1 | 2013 | 4092 | 0.050 |
Why?
|
HIV Long Terminal Repeat | 1 | 2001 | 88 | 0.050 |
Why?
|
Pregnancy Complications | 3 | 2005 | 2861 | 0.050 |
Why?
|
Colon | 1 | 2010 | 1772 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2022 | 63107 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 1999 | 183 | 0.050 |
Why?
|
Vagina | 1 | 2006 | 825 | 0.050 |
Why?
|
HIV Seronegativity | 2 | 2000 | 211 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 3873 | 0.050 |
Why?
|
TATA Box | 1 | 2001 | 128 | 0.050 |
Why?
|
DDT | 1 | 2001 | 31 | 0.050 |
Why?
|
Dietary Fats, Unsaturated | 2 | 2008 | 226 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3605 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2009 | 9240 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1357 | 0.050 |
Why?
|
Contact Tracing | 2 | 2020 | 273 | 0.050 |
Why?
|
Urban Population | 3 | 2006 | 2022 | 0.050 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7721 | 0.050 |
Why?
|
Postprandial Period | 1 | 2022 | 292 | 0.050 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2001 | 150 | 0.050 |
Why?
|
Malnutrition | 1 | 2007 | 625 | 0.050 |
Why?
|
Gait | 2 | 2024 | 793 | 0.050 |
Why?
|
Gene Dosage | 3 | 2010 | 1252 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 972 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1656 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2003 | 323 | 0.050 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2012 | 1458 | 0.050 |
Why?
|
Translocation, Genetic | 2 | 1986 | 1420 | 0.050 |
Why?
|
Resource Allocation | 1 | 1983 | 341 | 0.050 |
Why?
|
Ontario | 1 | 2001 | 383 | 0.050 |
Why?
|
Ultrasonography | 4 | 2001 | 5984 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1081 | 0.050 |
Why?
|
Recreation | 1 | 2001 | 115 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 117 | 0.050 |
Why?
|
Clavicle | 1 | 1983 | 209 | 0.050 |
Why?
|
Prostatitis | 1 | 2001 | 102 | 0.050 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2018 | 581 | 0.050 |
Why?
|
Gene Silencing | 1 | 2007 | 1539 | 0.050 |
Why?
|
Lipoproteins, HDL | 1 | 2005 | 638 | 0.050 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2004 | 657 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1641 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3405 | 0.050 |
Why?
|
AIDS Serodiagnosis | 1 | 2001 | 184 | 0.050 |
Why?
|
Bone Density Conservation Agents | 1 | 2008 | 772 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2002 | 458 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2005 | 587 | 0.050 |
Why?
|
Melatonin | 2 | 2003 | 721 | 0.050 |
Why?
|
Twins, Dizygotic | 1 | 2001 | 236 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2017 | 1862 | 0.050 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2016 | 1889 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2015 | 504 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2004 | 1263 | 0.050 |
Why?
|
Nutrition Policy | 2 | 2002 | 488 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 4639 | 0.040 |
Why?
|
Heart Ventricles | 1 | 1992 | 3817 | 0.040 |
Why?
|
T-Box Domain Proteins | 2 | 2012 | 471 | 0.040 |
Why?
|
Disclosure | 1 | 2006 | 736 | 0.040 |
Why?
|
Antigens, Surface | 1 | 2004 | 1663 | 0.040 |
Why?
|
Talc | 1 | 2000 | 47 | 0.040 |
Why?
|
Pigmentation | 1 | 2020 | 148 | 0.040 |
Why?
|
Axilla | 1 | 2022 | 597 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 1999 | 112 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 1997 | 2104 | 0.040 |
Why?
|
Death, Sudden, Cardiac | 1 | 2007 | 1541 | 0.040 |
Why?
|
Medication Errors | 1 | 2005 | 798 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2020 | 100 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 139 | 0.040 |
Why?
|
Group VI Phospholipases A2 | 1 | 2018 | 14 | 0.040 |
Why?
|
Transferrin | 2 | 2005 | 295 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 458 | 0.040 |
Why?
|
KCNQ1 Potassium Channel | 2 | 2010 | 104 | 0.040 |
Why?
|
Fetal Blood | 1 | 2005 | 1318 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2015 | 3464 | 0.040 |
Why?
|
Seafood | 1 | 2002 | 384 | 0.040 |
Why?
|
Colles' Fracture | 1 | 1998 | 11 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2010 | 546 | 0.040 |
Why?
|
Pain Measurement | 1 | 2009 | 3420 | 0.040 |
Why?
|
Cystitis, Interstitial | 1 | 1999 | 61 | 0.040 |
Why?
|
Sleep | 1 | 2014 | 4622 | 0.040 |
Why?
|
Riboflavin | 2 | 2015 | 108 | 0.040 |
Why?
|
Fluoridation | 1 | 1998 | 29 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3154 | 0.040 |
Why?
|
Osteomyelitis | 1 | 1983 | 402 | 0.040 |
Why?
|
Social Justice | 1 | 1983 | 457 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2013 | 1405 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1993 | 3338 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2005 | 1119 | 0.040 |
Why?
|
Pyrazoles | 1 | 2009 | 1972 | 0.040 |
Why?
|
Evaluation Studies as Topic | 4 | 1997 | 1681 | 0.040 |
Why?
|
Orthopedic Procedures | 1 | 2009 | 1289 | 0.040 |
Why?
|
Bone Resorption | 1 | 2002 | 723 | 0.040 |
Why?
|
Corneal Diseases | 1 | 2005 | 636 | 0.040 |
Why?
|
Genes, env | 1 | 1998 | 95 | 0.040 |
Why?
|
Trinucleotide Repeats | 2 | 2010 | 261 | 0.040 |
Why?
|
Stem Cell Factor | 1 | 2018 | 219 | 0.040 |
Why?
|
Energy Metabolism | 3 | 2015 | 2897 | 0.040 |
Why?
|
Health Status | 2 | 2017 | 4034 | 0.040 |
Why?
|
New South Wales | 1 | 2017 | 66 | 0.040 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2009 | 1414 | 0.040 |
Why?
|
Body Composition | 3 | 2010 | 2402 | 0.040 |
Why?
|
Spain | 2 | 2010 | 465 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1998 | 170 | 0.040 |
Why?
|
Water Pollutants | 1 | 2017 | 26 | 0.040 |
Why?
|
Contraceptive Devices, Female | 1 | 1998 | 43 | 0.040 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 1998 | 159 | 0.040 |
Why?
|
Placebos | 3 | 2009 | 1676 | 0.040 |
Why?
|
Myocardium | 2 | 2008 | 4772 | 0.040 |
Why?
|
Fluorides | 1 | 1998 | 127 | 0.040 |
Why?
|
Gestational Age | 4 | 2010 | 3493 | 0.040 |
Why?
|
Genetic Heterogeneity | 2 | 2012 | 733 | 0.040 |
Why?
|
Radius | 1 | 2001 | 422 | 0.040 |
Why?
|
Buttocks | 1 | 1998 | 110 | 0.040 |
Why?
|
Poisons | 1 | 1997 | 34 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 171 | 0.040 |
Why?
|
Cell Cycle | 1 | 2006 | 2967 | 0.040 |
Why?
|
Ferritins | 2 | 2005 | 590 | 0.040 |
Why?
|
Capsid Proteins | 1 | 2001 | 479 | 0.040 |
Why?
|
Temperature | 2 | 2014 | 2204 | 0.040 |
Why?
|
Soil Pollutants | 1 | 2017 | 71 | 0.040 |
Why?
|
Ulna Fractures | 1 | 1998 | 125 | 0.040 |
Why?
|
Causality | 2 | 2017 | 1275 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2001 | 733 | 0.040 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 1997 | 25 | 0.040 |
Why?
|
Glutamine | 1 | 2000 | 579 | 0.040 |
Why?
|
Confidentiality | 1 | 2001 | 612 | 0.040 |
Why?
|
Methylmercury Compounds | 1 | 1997 | 96 | 0.040 |
Why?
|
Vaginal Discharge | 1 | 1997 | 25 | 0.040 |
Why?
|
Patient Compliance | 2 | 2016 | 2684 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2013 | 4933 | 0.040 |
Why?
|
Upper Extremity | 1 | 2022 | 648 | 0.040 |
Why?
|
Lead | 1 | 2002 | 852 | 0.040 |
Why?
|
Malaria, Falciparum | 1 | 2005 | 1077 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6539 | 0.040 |
Why?
|
Diabetes, Gestational | 2 | 1997 | 1184 | 0.040 |
Why?
|
Primary Prevention | 1 | 2004 | 1167 | 0.040 |
Why?
|
Apoptosis | 2 | 2020 | 9724 | 0.040 |
Why?
|
Femoral Neck Fractures | 1 | 1998 | 138 | 0.040 |
Why?
|
Urinary Bladder | 2 | 2014 | 1173 | 0.040 |
Why?
|
New Hampshire | 2 | 2007 | 172 | 0.040 |
Why?
|
Chickens | 1 | 1999 | 865 | 0.040 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 1998 | 128 | 0.040 |
Why?
|
Lead Poisoning | 1 | 1999 | 301 | 0.040 |
Why?
|
Child Development | 2 | 2005 | 2223 | 0.040 |
Why?
|
Cyclophilins | 1 | 2016 | 46 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.040 |
Why?
|
Trans-Activators | 3 | 2015 | 2926 | 0.040 |
Why?
|
Databases, Nucleic Acid | 1 | 1997 | 211 | 0.030 |
Why?
|
Food Contamination | 1 | 1997 | 188 | 0.030 |
Why?
|
tRNA Methyltransferases | 1 | 2016 | 53 | 0.030 |
Why?
|
Contraceptive Agents | 1 | 1998 | 151 | 0.030 |
Why?
|
Contraceptives, Oral, Combined | 1 | 1997 | 113 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 7914 | 0.030 |
Why?
|
Asia | 1 | 2017 | 609 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 1988 | 1968 | 0.030 |
Why?
|
Seasons | 2 | 2007 | 1493 | 0.030 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1125 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2022 | 1262 | 0.030 |
Why?
|
Electromagnetic Fields | 1 | 1998 | 298 | 0.030 |
Why?
|
Microsatellite Instability | 2 | 2010 | 684 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2005 | 3395 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2017 | 299 | 0.030 |
Why?
|
Weight Loss | 2 | 2023 | 2625 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
Choice Behavior | 1 | 2001 | 802 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2018 | 3024 | 0.030 |
Why?
|
Recurrence | 3 | 2014 | 8340 | 0.030 |
Why?
|
Genomic Instability | 2 | 2010 | 695 | 0.030 |
Why?
|
Government Agencies | 1 | 2016 | 156 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3047 | 0.030 |
Why?
|
Blood Volume | 1 | 1997 | 565 | 0.030 |
Why?
|
Leisure Activities | 1 | 1997 | 311 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 1998 | 724 | 0.030 |
Why?
|
Multiple Myeloma | 2 | 2009 | 5181 | 0.030 |
Why?
|
Research Subjects | 1 | 1997 | 239 | 0.030 |
Why?
|
Conservation of Natural Resources | 1 | 2017 | 204 | 0.030 |
Why?
|
Walking | 1 | 2022 | 1180 | 0.030 |
Why?
|
Pain, Postoperative | 2 | 2005 | 1643 | 0.030 |
Why?
|
Formaldehyde | 1 | 2017 | 353 | 0.030 |
Why?
|
Periodontium | 1 | 2015 | 99 | 0.030 |
Why?
|
Light | 1 | 2001 | 1374 | 0.030 |
Why?
|
Algorithms | 5 | 2018 | 13882 | 0.030 |
Why?
|
Cytomegalovirus Infections | 1 | 2001 | 820 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1997 | 353 | 0.030 |
Why?
|
SEER Program | 1 | 2000 | 1507 | 0.030 |
Why?
|
Candidiasis | 1 | 1998 | 366 | 0.030 |
Why?
|
Quality of Life | 5 | 2024 | 12802 | 0.030 |
Why?
|
Adipocytes | 2 | 2015 | 1185 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2212 | 0.030 |
Why?
|
Plant Oils | 1 | 1996 | 202 | 0.030 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2014 | 49 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2001 | 1783 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1999 | 952 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 236 | 0.030 |
Why?
|
Genome | 3 | 2011 | 1807 | 0.030 |
Why?
|
Educational Measurement | 1 | 2001 | 1210 | 0.030 |
Why?
|
History, Ancient | 1 | 2015 | 212 | 0.030 |
Why?
|
Epithelium | 1 | 1999 | 1679 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2010 | 10483 | 0.030 |
Why?
|
Spermatocidal Agents | 1 | 1994 | 15 | 0.030 |
Why?
|
Syphilis Serodiagnosis | 1 | 1994 | 35 | 0.030 |
Why?
|
Insulin Resistance | 3 | 2015 | 3864 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2015 | 170 | 0.030 |
Why?
|
Anovulation | 1 | 1994 | 58 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 68 | 0.030 |
Why?
|
Silicones | 1 | 1995 | 250 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2015 | 157 | 0.030 |
Why?
|
Vaginal Smears | 2 | 1974 | 511 | 0.030 |
Why?
|
Self Disclosure | 1 | 1995 | 251 | 0.030 |
Why?
|
Motor Activity | 1 | 2004 | 2715 | 0.030 |
Why?
|
England | 1 | 2015 | 522 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
Alveolar Process | 1 | 2015 | 293 | 0.030 |
Why?
|
Anorexia Nervosa | 2 | 1995 | 1286 | 0.030 |
Why?
|
Stromal Cells | 1 | 1999 | 1355 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5882 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 1994 | 315 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2018 | 728 | 0.030 |
Why?
|
Computer Simulation | 3 | 2017 | 6194 | 0.030 |
Why?
|
Chlorine | 1 | 1993 | 50 | 0.030 |
Why?
|
Growth | 1 | 1996 | 376 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Self Efficacy | 1 | 2017 | 615 | 0.030 |
Why?
|
Vaginal Neoplasms | 1 | 1974 | 106 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
Castration | 1 | 1973 | 159 | 0.030 |
Why?
|
beta-Carotene 15,15'-Monooxygenase | 1 | 2013 | 12 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1997 | 1572 | 0.030 |
Why?
|
Longevity | 1 | 2021 | 1071 | 0.030 |
Why?
|
Hemoglobin A | 1 | 1993 | 87 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1994 | 305 | 0.030 |
Why?
|
California | 1 | 1997 | 1402 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2015 | 211 | 0.030 |
Why?
|
Sterilization, Tubal | 1 | 1993 | 87 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 12961 | 0.030 |
Why?
|
Bone and Bones | 2 | 2021 | 2576 | 0.030 |
Why?
|
Isosorbide Dinitrate | 1 | 1993 | 34 | 0.030 |
Why?
|
Heroin | 1 | 1993 | 117 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 3508 | 0.030 |
Why?
|
Diet, Fat-Restricted | 1 | 1996 | 320 | 0.030 |
Why?
|
Glucose | 2 | 2019 | 4398 | 0.030 |
Why?
|
Italy | 1 | 2015 | 832 | 0.030 |
Why?
|
Mutagens | 1 | 2013 | 168 | 0.030 |
Why?
|
Sulfur | 1 | 1993 | 166 | 0.030 |
Why?
|
Staff Development | 1 | 2015 | 223 | 0.030 |
Why?
|
Glucose Tolerance Test | 2 | 2012 | 1151 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1998 | 1000 | 0.030 |
Why?
|
Cholelithiasis | 1 | 1994 | 414 | 0.030 |
Why?
|
Mouth | 1 | 2015 | 374 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2804 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 1993 | 163 | 0.030 |
Why?
|
Radius Fractures | 1 | 1998 | 501 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2002 | 2278 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 1995 | 264 | 0.030 |
Why?
|
Prostate | 2 | 2011 | 1775 | 0.030 |
Why?
|
Dioxygenases | 1 | 2014 | 316 | 0.030 |
Why?
|
Patient Participation | 1 | 2001 | 1457 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2251 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 315 | 0.030 |
Why?
|
Survival Rate | 3 | 2012 | 12788 | 0.030 |
Why?
|
Colonoscopy | 3 | 2009 | 1367 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 700 | 0.030 |
Why?
|
Fetal Death | 3 | 2005 | 448 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2004 | 2291 | 0.030 |
Why?
|
Sweden | 2 | 2009 | 1341 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4751 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2015 | 365 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2012 | 235 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 159 | 0.030 |
Why?
|
Pakistan | 1 | 2012 | 295 | 0.030 |
Why?
|
Contraceptive Devices, Male | 1 | 1991 | 13 | 0.030 |
Why?
|
Liver | 3 | 2015 | 7475 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.020 |
Why?
|
Survivors | 1 | 2022 | 2291 | 0.020 |
Why?
|
Faculty | 1 | 2015 | 387 | 0.020 |
Why?
|
DNA Primase | 1 | 2012 | 109 | 0.020 |
Why?
|
Point Mutation | 1 | 1997 | 1624 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7282 | 0.020 |
Why?
|
Breast Implants | 1 | 1995 | 387 | 0.020 |
Why?
|
Work | 1 | 2012 | 191 | 0.020 |
Why?
|
Family Health | 2 | 2009 | 1281 | 0.020 |
Why?
|
Methadone | 1 | 1993 | 306 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.020 |
Why?
|
Problem-Based Learning | 1 | 2015 | 361 | 0.020 |
Why?
|
Retrospective Studies | 7 | 2023 | 77460 | 0.020 |
Why?
|
Private Sector | 1 | 1994 | 392 | 0.020 |
Why?
|
Laminin | 1 | 2012 | 419 | 0.020 |
Why?
|
Keratin-5 | 1 | 2010 | 46 | 0.020 |
Why?
|
Organizational Culture | 1 | 2015 | 510 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4479 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1999 | 2924 | 0.020 |
Why?
|
Occupational Health | 1 | 2017 | 808 | 0.020 |
Why?
|
Mercury | 1 | 1993 | 285 | 0.020 |
Why?
|
International Cooperation | 1 | 2017 | 1420 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 2 | 2005 | 440 | 0.020 |
Why?
|
Copper | 1 | 1993 | 366 | 0.020 |
Why?
|
Pre-Eclampsia | 2 | 1999 | 1200 | 0.020 |
Why?
|
Religion | 1 | 2014 | 356 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 2012 | 180 | 0.020 |
Why?
|
Africa | 1 | 1993 | 672 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3537 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
Vitamin E Deficiency | 1 | 2010 | 32 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2005 | 4043 | 0.020 |
Why?
|
Dogs | 2 | 1993 | 3912 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2014 | 604 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 73 | 0.020 |
Why?
|
Ventricular Function | 1 | 1992 | 415 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 876 | 0.020 |
Why?
|
Cyprus | 1 | 2010 | 79 | 0.020 |
Why?
|
Pilot Projects | 2 | 2018 | 8319 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
Hip Fractures | 1 | 1998 | 955 | 0.020 |
Why?
|
Glycosyltransferases | 1 | 2010 | 113 | 0.020 |
Why?
|
Magnesium | 1 | 1993 | 813 | 0.020 |
Why?
|
HIV Core Protein p24 | 2 | 2001 | 256 | 0.020 |
Why?
|
Sulfites | 1 | 2010 | 78 | 0.020 |
Why?
|
Agouti Signaling Protein | 1 | 2009 | 21 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 147 | 0.020 |
Why?
|
Integrin beta Chains | 1 | 2010 | 121 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 977 | 0.020 |
Why?
|
Soil | 1 | 1990 | 106 | 0.020 |
Why?
|
Caspase 10 | 1 | 2009 | 4 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2003 | 2758 | 0.020 |
Why?
|
Vitamin A Deficiency | 1 | 2010 | 101 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2013 | 721 | 0.020 |
Why?
|
Blood Sedimentation | 1 | 2010 | 231 | 0.020 |
Why?
|
Health Planning Technical Assistance | 1 | 2009 | 6 | 0.020 |
Why?
|
Metabolome | 1 | 2016 | 895 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2010 | 194 | 0.020 |
Why?
|
Patient Selection | 1 | 2001 | 4216 | 0.020 |
Why?
|
Community Health Centers | 1 | 1993 | 430 | 0.020 |
Why?
|
Acute Disease | 2 | 1994 | 7147 | 0.020 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2009 | 62 | 0.020 |
Why?
|
Genital Neoplasms, Female | 1 | 2015 | 523 | 0.020 |
Why?
|
Chromosome Banding | 2 | 1986 | 278 | 0.020 |
Why?
|
Maternal Age | 3 | 1997 | 802 | 0.020 |
Why?
|
Health Transition | 1 | 2009 | 34 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1169 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1992 | 620 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 806 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2015 | 1352 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 92 | 0.020 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2009 | 76 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3307 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2011 | 209 | 0.020 |
Why?
|
Fetal Distress | 1 | 1988 | 40 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1993 | 525 | 0.020 |
Why?
|
Anti-HIV Agents | 2 | 2009 | 4255 | 0.020 |
Why?
|
Affective Disorders, Psychotic | 1 | 1990 | 191 | 0.020 |
Why?
|
Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
Prenatal Diagnosis | 2 | 1988 | 1236 | 0.020 |
Why?
|
Hawaii | 1 | 2008 | 105 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5918 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2012 | 486 | 0.020 |
Why?
|
Osteoporosis | 1 | 1998 | 1579 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1998 | 1771 | 0.020 |
Why?
|
Camptothecin | 1 | 2012 | 576 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 219 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2749 | 0.020 |
Why?
|
Interleukin-16 | 1 | 2008 | 33 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6621 | 0.020 |
Why?
|
INDEL Mutation | 1 | 2009 | 279 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2008 | 231 | 0.020 |
Why?
|
Family | 3 | 2010 | 3147 | 0.020 |
Why?
|
Oxytocin | 1 | 1992 | 394 | 0.020 |
Why?
|
Taq Polymerase | 1 | 2007 | 19 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21833 | 0.020 |
Why?
|
United Nations | 1 | 2009 | 165 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 504 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3130 | 0.020 |
Why?
|
Los Angeles | 1 | 2008 | 238 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1995 | 1678 | 0.020 |
Why?
|
Life Change Events | 1 | 1993 | 938 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2009 | 444 | 0.020 |
Why?
|
Organizations | 1 | 2009 | 170 | 0.020 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2007 | 70 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3582 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2716 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1590 | 0.020 |
Why?
|
Interinstitutional Relations | 1 | 2009 | 241 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.020 |
Why?
|
Asia, Southeastern | 1 | 2007 | 111 | 0.020 |
Why?
|
Infant, Premature | 2 | 2005 | 2045 | 0.020 |
Why?
|
Relief Work | 1 | 2009 | 137 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2926 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2011 | 890 | 0.020 |
Why?
|
Random Allocation | 3 | 1998 | 2428 | 0.020 |
Why?
|
Japan | 1 | 2011 | 1360 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2013 | 1047 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1993 | 857 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2008 | 250 | 0.020 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2007 | 142 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2008 | 272 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2009 | 438 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5096 | 0.020 |
Why?
|
Boston | 3 | 2003 | 9312 | 0.020 |
Why?
|
China | 1 | 2012 | 2245 | 0.020 |
Why?
|
Qualitative Research | 1 | 2015 | 2682 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2016 | 1708 | 0.020 |
Why?
|
Chromatin | 1 | 2018 | 2933 | 0.020 |
Why?
|
Amniotic Fluid | 1 | 1988 | 370 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 514 | 0.020 |
Why?
|
DNA Replication | 2 | 2007 | 1399 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16690 | 0.020 |
Why?
|
Carbonated Beverages | 1 | 2007 | 214 | 0.020 |
Why?
|
Virus Shedding | 1 | 2006 | 108 | 0.020 |
Why?
|
Calcium | 2 | 2004 | 5755 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 648 | 0.020 |
Why?
|
Leukemia | 1 | 1994 | 1510 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 328 | 0.020 |
Why?
|
Arthrography | 1 | 2007 | 149 | 0.020 |
Why?
|
Adipokines | 1 | 2008 | 320 | 0.020 |
Why?
|
Occupational Exposure | 1 | 1996 | 1793 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1856 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 769 | 0.020 |
Why?
|
MEDLINE | 1 | 2006 | 125 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2017 | 1796 | 0.020 |
Why?
|
Poverty | 1 | 2017 | 2660 | 0.020 |
Why?
|
Scotland | 2 | 1995 | 155 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2598 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1378 | 0.020 |
Why?
|
Public Health Nursing | 1 | 2005 | 15 | 0.020 |
Why?
|
Leadership | 1 | 2015 | 1357 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.020 |
Why?
|
Lymphoma | 1 | 1994 | 1877 | 0.020 |
Why?
|
Synapses | 1 | 2015 | 1728 | 0.020 |
Why?
|
Science | 1 | 2008 | 241 | 0.020 |
Why?
|
Databases, Factual | 2 | 2014 | 7730 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2007 | 684 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81201 | 0.020 |
Why?
|
Androstenedione | 1 | 2004 | 131 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2009 | 674 | 0.020 |
Why?
|
Acetazolamide | 1 | 1984 | 100 | 0.020 |
Why?
|
Food | 1 | 1989 | 772 | 0.020 |
Why?
|
Food Supply | 1 | 1990 | 524 | 0.020 |
Why?
|
Neopterin | 2 | 1994 | 56 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
Acclimatization | 1 | 1984 | 103 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2007 | 3778 | 0.020 |
Why?
|
Estrogens, Catechol | 1 | 2004 | 25 | 0.020 |
Why?
|
Oxygen Consumption | 2 | 1984 | 1868 | 0.020 |
Why?
|
Fetus | 2 | 2002 | 1880 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1671 | 0.020 |
Why?
|
Glucuronides | 1 | 2004 | 20 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1596 | 0.020 |
Why?
|
Allopurinol | 1 | 2005 | 191 | 0.020 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2004 | 68 | 0.020 |
Why?
|
Muscular Dystrophies | 1 | 1986 | 393 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4222 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2009 | 695 | 0.010 |
Why?
|
Peer Review, Research | 1 | 2007 | 329 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2499 | 0.010 |
Why?
|
Fasting | 1 | 2010 | 1592 | 0.010 |
Why?
|
Hemochromatosis | 1 | 2005 | 184 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2009 | 817 | 0.010 |
Why?
|
Blood Donors | 1 | 1986 | 355 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3144 | 0.010 |
Why?
|
Heterosexuality | 1 | 2006 | 276 | 0.010 |
Why?
|
Nepal | 1 | 1984 | 295 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 2005 | 296 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2007 | 2050 | 0.010 |
Why?
|
Air Pollutants | 1 | 2017 | 2816 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3553 | 0.010 |
Why?
|
Memory | 1 | 1993 | 2174 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2009 | 970 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2006 | 641 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1060 | 0.010 |
Why?
|
Cordocentesis | 1 | 2002 | 8 | 0.010 |
Why?
|
Chlamydophila pneumoniae | 1 | 2003 | 55 | 0.010 |
Why?
|
Solar System | 1 | 2002 | 12 | 0.010 |
Why?
|
Survival | 1 | 2003 | 163 | 0.010 |
Why?
|
Cadherins | 1 | 2008 | 907 | 0.010 |
Why?
|
Actins | 1 | 2011 | 2121 | 0.010 |
Why?
|
Wisconsin | 1 | 2002 | 124 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 619 | 0.010 |
Why?
|
Administration, Oral | 2 | 2005 | 3914 | 0.010 |
Why?
|
Beer | 1 | 2002 | 127 | 0.010 |
Why?
|
Verbal Learning | 1 | 2005 | 468 | 0.010 |
Why?
|
Antimalarials | 1 | 2009 | 905 | 0.010 |
Why?
|
Pelvic Pain | 1 | 2004 | 274 | 0.010 |
Why?
|
Politics | 1 | 2009 | 791 | 0.010 |
Why?
|
Respiration Disorders | 1 | 2005 | 371 | 0.010 |
Why?
|
Secretory Rate | 1 | 2001 | 82 | 0.010 |
Why?
|
Nursing Research | 1 | 2002 | 77 | 0.010 |
Why?
|
Hydrops Fetalis | 1 | 2002 | 107 | 0.010 |
Why?
|
Stem Cells | 1 | 2015 | 3567 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 1941 | 0.010 |
Why?
|
Wine | 1 | 2002 | 165 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8662 | 0.010 |
Why?
|
Pulmonary Edema | 1 | 1984 | 414 | 0.010 |
Why?
|
Emotions | 1 | 2013 | 2659 | 0.010 |
Why?
|
Parasitic Diseases | 1 | 2001 | 75 | 0.010 |
Why?
|
Pregnancy Rate | 1 | 2004 | 643 | 0.010 |
Why?
|
Personality Inventory | 1 | 2004 | 1030 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2282 | 0.010 |
Why?
|
Maternal Welfare | 1 | 2001 | 115 | 0.010 |
Why?
|
Disease Notification | 1 | 2001 | 97 | 0.010 |
Why?
|
Middle Cerebral Artery | 1 | 2002 | 264 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1692 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 651 | 0.010 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2005 | 455 | 0.010 |
Why?
|
Gases | 1 | 2001 | 197 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2009 | 1872 | 0.010 |
Why?
|
Pineal Gland | 1 | 2001 | 166 | 0.010 |
Why?
|
Brain | 2 | 2023 | 26388 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3773 | 0.010 |
Why?
|
Peritoneum | 1 | 2001 | 228 | 0.010 |
Why?
|
Systole | 1 | 2002 | 958 | 0.010 |
Why?
|
Gene Products, gag | 1 | 2001 | 337 | 0.010 |
Why?
|
Daucus carota | 1 | 1999 | 10 | 0.010 |
Why?
|
Physical Fitness | 1 | 1984 | 732 | 0.010 |
Why?
|
Brain Edema | 1 | 1984 | 617 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 2002 | 571 | 0.010 |
Why?
|
Obstetric Labor, Premature | 1 | 2001 | 279 | 0.010 |
Why?
|
Methyltransferases | 1 | 2003 | 367 | 0.010 |
Why?
|
Cesarean Section | 1 | 1988 | 1365 | 0.010 |
Why?
|
Gene Products, env | 1 | 2001 | 263 | 0.010 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 222 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 2002 | 732 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2004 | 1802 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2009 | 1714 | 0.010 |
Why?
|
Amenorrhea | 1 | 2003 | 485 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2008 | 1148 | 0.010 |
Why?
|
Drug Utilization | 1 | 2005 | 1183 | 0.010 |
Why?
|
Lighting | 1 | 2001 | 231 | 0.010 |
Why?
|
HIV Antibodies | 1 | 1986 | 1322 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2008 | 2441 | 0.010 |
Why?
|
Software | 1 | 2013 | 4441 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2002 | 1423 | 0.010 |
Why?
|
Body Burden | 1 | 1999 | 158 | 0.010 |
Why?
|
Perineum | 1 | 2000 | 211 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1983 | 2031 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2005 | 977 | 0.010 |
Why?
|
Pyridoxine | 1 | 1998 | 102 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3690 | 0.010 |
Why?
|
Forearm Injuries | 1 | 1998 | 67 | 0.010 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 1998 | 65 | 0.010 |
Why?
|
Capsid | 1 | 2001 | 437 | 0.010 |
Why?
|
Image Enhancement | 1 | 2009 | 2921 | 0.010 |
Why?
|
Lymphatic Diseases | 1 | 1980 | 323 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 961 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3511 | 0.010 |
Why?
|
Rectal Neoplasms | 2 | 1999 | 1205 | 0.010 |
Why?
|
Pedigree | 1 | 1985 | 4642 | 0.010 |
Why?
|
Biological Availability | 1 | 1998 | 397 | 0.010 |
Why?
|
Arsenic Poisoning | 1 | 1997 | 55 | 0.010 |
Why?
|
Lung Diseases, Obstructive | 1 | 1978 | 316 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2001 | 780 | 0.010 |
Why?
|
Drug Combinations | 1 | 2002 | 1958 | 0.010 |
Why?
|
Nutritive Value | 1 | 2000 | 339 | 0.010 |
Why?
|
Dopamine | 1 | 2004 | 1591 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2003 | 1470 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5451 | 0.010 |
Why?
|
Tetrahydrofolates | 1 | 1997 | 61 | 0.010 |
Why?
|
Diphosphoglyceric Acids | 1 | 1976 | 32 | 0.010 |
Why?
|
Schizophrenia | 1 | 1995 | 6882 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2010 | 3326 | 0.010 |
Why?
|
Analgesia | 1 | 2001 | 461 | 0.010 |
Why?
|
Biometry | 1 | 1999 | 558 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11366 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 1999 | 723 | 0.010 |
Why?
|
Bone Diseases, Metabolic | 1 | 1999 | 417 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.010 |
Why?
|
Romania | 1 | 1994 | 96 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1982 | 1178 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1978 | 1617 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2003 | 4561 | 0.010 |
Why?
|
Immunity, Active | 1 | 1993 | 60 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 2147 | 0.010 |
Why?
|
Death Certificates | 1 | 1994 | 169 | 0.010 |
Why?
|
Hyperplasia | 1 | 1997 | 1185 | 0.010 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1995 | 275 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 1998 | 582 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5660 | 0.010 |
Why?
|
Abdomen | 1 | 1999 | 1118 | 0.010 |
Why?
|
Counseling | 1 | 2001 | 1523 | 0.010 |
Why?
|
Sigmoidoscopy | 1 | 1994 | 156 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 1999 | 1725 | 0.010 |
Why?
|
Premature Birth | 1 | 2005 | 1721 | 0.010 |
Why?
|
Electric Injuries | 1 | 1993 | 26 | 0.010 |
Why?
|
Contraceptive Agents, Female | 1 | 1995 | 135 | 0.010 |
Why?
|
Kidney | 1 | 1988 | 7184 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1973 | 919 | 0.010 |
Why?
|
Asthma | 1 | 2011 | 6010 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1994 | 513 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19233 | 0.010 |
Why?
|
Community Mental Health Services | 1 | 1995 | 386 | 0.010 |
Why?
|
Sex Education | 1 | 1992 | 93 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2005 | 6994 | 0.010 |
Why?
|
Narcotics | 1 | 1993 | 343 | 0.010 |
Why?
|
Body Temperature | 1 | 1974 | 777 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 1998 | 875 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 1 | 1973 | 744 | 0.010 |
Why?
|
Luteinizing Hormone | 1 | 1973 | 869 | 0.010 |
Why?
|
Health Expenditures | 1 | 1983 | 2349 | 0.010 |
Why?
|
Birth Order | 1 | 1990 | 95 | 0.010 |
Why?
|
Blood Proteins | 1 | 1994 | 1124 | 0.010 |
Why?
|
Cell Division | 1 | 1997 | 4569 | 0.010 |
Why?
|
Hepatitis B | 1 | 1994 | 695 | 0.010 |
Why?
|
Marriage | 1 | 1990 | 339 | 0.000 |
Why?
|
Postoperative Care | 1 | 1974 | 1487 | 0.000 |
Why?
|
Cluster Analysis | 1 | 1994 | 2715 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13814 | 0.000 |
Why?
|
Erythrocytes | 1 | 1976 | 2455 | 0.000 |
Why?
|
Exercise Test | 1 | 1993 | 2073 | 0.000 |
Why?
|
Decision Making | 1 | 1979 | 3888 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1986 | 1375 | 0.000 |
Why?
|
Biopsy | 1 | 1997 | 6755 | 0.000 |
Why?
|
Social Environment | 1 | 1990 | 1022 | 0.000 |
Why?
|
X Chromosome | 1 | 1986 | 814 | 0.000 |
Why?
|
Hemodynamics | 1 | 1993 | 4196 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1995 | 3531 | 0.000 |
Why?
|
Cyclothymic Disorder | 1 | 1982 | 41 | 0.000 |
Why?
|
Coronary Angiography | 1 | 1993 | 4576 | 0.000 |
Why?
|
Syndrome | 1 | 1986 | 3252 | 0.000 |
Why?
|
Platelet Count | 1 | 1982 | 780 | 0.000 |
Why?
|
Electrocardiography | 1 | 1993 | 6442 | 0.000 |
Why?
|
Closing Volume | 1 | 1978 | 3 | 0.000 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1978 | 25 | 0.000 |
Why?
|
Residual Volume | 1 | 1978 | 41 | 0.000 |
Why?
|
Functional Residual Capacity | 1 | 1978 | 68 | 0.000 |
Why?
|
Partial Pressure | 1 | 1978 | 254 | 0.000 |
Why?
|
Pharyngeal Diseases | 1 | 1980 | 133 | 0.000 |
Why?
|
Total Lung Capacity | 1 | 1978 | 143 | 0.000 |
Why?
|
Nitrogen | 1 | 1978 | 344 | 0.000 |
Why?
|
Personality Disorders | 1 | 1982 | 713 | 0.000 |
Why?
|
Leg | 1 | 1982 | 1116 | 0.000 |
Why?
|
Vital Capacity | 1 | 1978 | 925 | 0.000 |
Why?
|
Hospitalization | 1 | 1995 | 10259 | 0.000 |
Why?
|
Spirometry | 1 | 1978 | 865 | 0.000 |
Why?
|
Neck | 1 | 1980 | 698 | 0.000 |
Why?
|
Maternal-Fetal Exchange | 1 | 1976 | 456 | 0.000 |
Why?
|
Forced Expiratory Volume | 1 | 1978 | 1745 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1973 | 15297 | 0.000 |
Why?
|
Depressive Disorder | 1 | 1982 | 3747 | 0.000 |
Why?
|
Oxygen | 1 | 1978 | 4189 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 1982 | 5027 | 0.000 |
Why?
|